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ABSTRACT 
 The lipid bilayer membrane of enveloped viruses, such as human 
immunodeficiency virus type 1 (HIV-1), plays an important role in key steps of the 
infection, including cell binding and uptake. Phosphatidylserine (PS) and 
monosialotetrahexosylganglioside (GM1) are examples of two host-derived lipids in 
the membrane of enveloped virus particles that are known to contribute to virus 
attachment, uptake, and ultimately dissemination. A quantitative characterization 
of their contribution to the functionality of the virus requires information about 
their relative concentrations in the viral membrane. In this dissertation, a gold 
nanoparticle (NP) binding assay for probing relative PS and GM1 lipid concentrations 
in the outer leaflet of different virus-like particles (VLPs) using small sample sizes is 
introduced. The assay evaluates both scattering intensity and resonance wavelength 
and determines relative NP densities through plasmon coupling as a measure for 
the target lipid concentrations in the NP-labeled VLP membrane. The performed 
studies reveal significant differences in the membrane of HIV-1 and Ebola VLPs that 
assemble at different intracellular sites and pave the way to an optical quantification 
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of lipid concentration in virus particles at physiological titers. In addition, this 
technique was used in another application to improve the understanding of the 
relationship between the membrane PS lipid and the infectivity of HIV-2 and murine 
leukemia virus (MLV). 
The composition of the membrane, in particular the cholesterol (chol) 
content, determines its fluidity. As differences in the membrane composition of 
individual virus particles can lead to different intracellular fates, biophysical tools 
capable of probing the membrane fluidity on the single-virus level are required. In 
this dissertation, we demonstrate that fluctuations in the polarization of light 
scattered off gold or silver nanoparticle (NP)-labeled virus-like-particles (VLPs) 
encode information about the membrane fluidity of individual VLPs. We developed 
a plasmonic polarization fluctuation tracking microscopy (PFTM) which facilitated, 
for the first time, the investigation of the effect of chol content on the membrane 
fluidity and its dependence on temperature on the single-VLP level. Chol extraction 
studies with different methyl-β-cyclodextrin (MβCD) concentrations yielded a 
gradual decrease in polarization fluctuations as function of time. The PFTM revealed 
chol content and fluidity heterogeneities of an HIV-1 VLP population. 
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Chapter 1 INTRODUCTION 
The lipid bilayer membrane of enveloped viruses has been found to be significantly 
more active than being a simple container for carrying the genome and glycoproteins. 
The conventional understanding of the enveloped viruses’ life cycle has been based 
on the conception that these viruses use their surface glycoproteins to bind to cell 
surface receptors and fuse with their membranes1–3. This was true until glycoprotein-
independent pathways were discovered for the viruses to be captured by certain host 
cells4,5. These viruses are enveloped in a host-derived lipid bilayer which contains 
various types of lipids, each of which play some role in regulating, not only, the 
mechanical6 and physical7 properties, but also, the biological interactions4 of the 
membrane.  
Human immunodeficiency virus (HIV) is an example of the enveloped viruses that 
uses its surface glycoprotein gp120 in binding to CD4+ T cells. However, it was found 
that this virus can also get captured by dendritic cells (DCs) in a glycoprotein-
independent manner4,5. The interaction of HIV with DCs occurs through the 
binding of viral membrane-incorporated glycosphingolipids (GSLs), particularly 
GM3, with CD169 receptors on the surface of DCs. In addition, other researches 
showed the importance of the mechanical properties of the viral membrane, such as 
its phase and fluidity, in the viral infectivity6,8, and the cholesterol (chol) content of 
the membrane was found to be regulating this mechanical property9. Such 
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discoveries attracted a great deal interest in the lipidome of the enveloped 
viruses10,11, in addition to the phase behavior of their membranes and their effects on 
the infectivity. The conventional techniques for measuring lipid content and 
membrane fluidity have been mass spectrometry (MS), nuclear magnetic resonance 
(NMR) and electron spin resonance (ESR) spectrometries and fluorescence 
techniques. However, the major limitation of these techniques is the relatively large 
sample requirement which is difficult to obtain from patient-derived samples, as far 
as clinical relevance is concerned. Fluorescence techniques may be able to work with 
smaller sample amounts but they usually suffer from low photostability of 
fluorophores and, therefore, low precision and weakness for fast time-resolved 
measurements. 
Plasmonic nanoparticles (NPs) have been used as labels for biological 
characterization in many different applications. They have been shown to offer 
advantageous photophysical properties such as high photostability, absorption and 
scattering cross sections, and, consequently, the capability to utilize them in 
microscopy-based assays, which makes them extremely suitable for small-sample 
measurements.12 In addition, the distance dependent plasmon coupling between 
these nanoparticles provides us with the ability to perform target density and 
concentration measurements and track the system dynamics with a relatively high 
speed, up to nearly 1 kHz.13 
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This chapter provides a general introduction of the enveloped viruses, with a special 
focus on HIV, which will continue with an overview of its membrane composition 
and fluidity and the conventional techniques that are normally used for their 
quantification. Subsequently, the functional relationship among viral membrane 
lipid composition, fluidity and infectivity will be discussed, and the need for small-
sample measurements, based on the relevance of such quantification on patient-
derived samples with low virion concentration, will be explained. Finally, some 
basics of the applications of plasmonic nanoparticles will be provided and the 
plasmonics-based technologies available for biological characterization will be 
overviewed, to explain the basis on which the techniques presented in this 
dissertation are developed. 
 1.1 The Structure of Enveloped Viruses  
Enveloped viruses are a class of viruses that obtain a lipid bilayer membrane 
(envelope) through the process of budding out of the host cell membranes. These 
viruses are mainly composed of genome enclosed in a capsid shell covered in a lipid 
bilayer membrane. The envelope is usually supported by a matrix protein attached 
beneath it and, in addition to the lipids, contains glycoproteins essential for certain 
pathways of cell binding and membrane fusion14. The capsid can have different 
geometric shapes depending on the particular type of the virus and the 
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crystallography of the protein that forms it and its role is to enclose and protect the 
genome and proteins required for its replication15. 
Human immunodeficiency virus type 1 (HIV-1) is an enveloped retrovirus discovered 
in 1983, illustrated in Figure 1.1. The structural polyprotein of HIV-1 is called Gag and 
it is composed of p17, p24, p7 and p6 proteins16,17. Its conical capsid, which forms 
through the process of virion maturation and detachment of p24 from p17, is 
composed of nearly 200 copies of p24 protein and encloses two copies of a single 
stranded RNA, p6 and p7 proteins and enzymes necessary for the RNA replication18. 
HIV-1’s matrix protein is p17 which remains bound to the inner leaflet of the viral 
membrane after maturation through its positively charged moieties. Finally, its 
envelope is mainly composed of several units of a complex of glycoproteins, gp41 
and gp120 (Env), in addition to thousands of lipids of various types, mainly including 
chol, phospholipids, sphingolipids and gangliosides, a type of GSLs19. 
 
Figure 1.1 The 3D illustration of the structure of a mature HIV-1 virion. It includes the genome in the 
core, conical capsid and the envelope containing a lipid bilayer and glycoproteins. Reprinted with 
permission from Visual Science. © 2016 Visual Science, www.visual-science.com. 
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1.2 Viral Membrane Lipid Composition Quantification 
Lipidomics is a category of Metabolomics in which cellular and viral lipids and their 
production pathways are studied. An essential part of lipidomics is the lipid 
quantification, which is conventionally performed through lipid extraction, 
separation and finally detection by Mass Spectrometry (MS). The most common 
types of MS used for lipid quantification have been electrospray ionization (ESI), 
matrix-assisted laser desorption/ionization (MALDI) and atmospheric pressure 
chemical ionization (APCI) MS. Through these techniques the lipid compositions at 
different scales including virus, cell, tissue, organism and ecosystem have been 
quantified20–22. 
Viral lipid composition quantification is helpful both in detecting the source of the 
virus generation and also in studying the bioactive lipids on the virion surface which 
play crucial roles in virus – host-cell interactions5,11. Consequently, during the past 
few decades, various enveloped viruses have been subject to detailed lipidomics 
analyses in order for their better understanding and developing useful therapeutic 
strategies against them11,23–25. In the case of HIV, various research groups have 
reported the lipidome quantification, the most comprehensive one of which was 
done by R. Chan et. al. through ESI-MS11. As reported in that study, for HIV and 
murine leukemia virus (MLV) (Figure 1.2) the viral lipidomes resemble the 
respective host plasma membranes but are enriched in particular lipids. These lipids 
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are chol, ceramide, GM3 and phsophoinositides such as phosphatidylinositol 4,5-
bisphosphate [PI(4,5)P2]. In addition, these studies have revealed the following mole 
percentages in the envelope of wild-type (WT) HIV-1 virions: nearly 40% chol, 11-
13.5% phosphatidylserine (PS) and only less than 3% GM3 and GM1. However, 
precise quantification of GM3 and GM1 gangliosides has faced some difficulty due 
to complex structure of these lipids’ head groups and the consequent complications 
in the mass spectrum analysis and also technical problems such as lack of 
appropriate reference samples for their calibration. These reports have suggested 
that the special lipid compositions of HIV and MLV are indicative of a budding 
process through chol-rich lipid rafts in the host cell plasma membrane.  
 
Figure 1.2 Ratio of retroviral and microvesicle (MV) lipid composition to plasma membrane lipid 
composition. Lipids that are significantly enriched (>1.5-fold) or reduced (<1.5-fold) in viral envelopes 
are highlighted in red and green, respectively. Reprinted with permission from ref. 11. © 2008 
American Society for Microbiology. 
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1.3 Viral Membrane Fluidity Quantification 
Fluidity is the inverse of viscosity and it is directly related to the molecular structure 
of the lipids that compose the membrane and non-covalent interactions between 
them26. Ultimately, these factors determine the diffusion coefficient of a particular 
lipid.  Membrane viscosity (ɳ) is related to the lipids’ diffusion coefficient (D) 
through the Stokes-Einstein equation: 
𝐷 =  
𝑘𝐵𝑇
6𝜋ɳ𝑟
 1.1 
where 𝑘𝐵 is the Boltzmann constant, T is temperature, and r is the particle or lipid 
radius. Therefore, membrane fluidity, which depends on the molecular structure of 
the lipids and their non-covalent interactions, together with temperature and size 
of the lipids determine the lipids diffusion coefficient in the membrane. 
The effect of chol on membrane fluidity depends on the temperature relative to the 
solid-ordered (So) to liquid-disordered (Ld) phase transition temperature (Tm). 
Below the transition temperature, chol fluidizes the membrane, while for 
temperatures above the transition temperature it rigidifies the membrane27,28. On 
the ensemble level, the temperature-dependent correlation between cholesterol 
content and membrane fluidity has been extensively studied in liposome and virus 
systems using several different tenchniques29–32.  Figure 1.3 shows the change in the 
fluidity and Tm of HIV-1 membrane before and after chol extraction9. At high 
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temperature (roughly above 40 ˚C), decreasing the chol content strongly increases 
the membrane fluidity. 
 
Figure 1.3 Laurdan GP values calculated for each temperature and displayed for particles treated 
(dashed line) or not treated (solid line) with Mβ-CD. The Tm is indicated by the arrow. Error bars 
represent standard deviation of the mean. Reprinted with permission from ref. 9. © 2009 The Journal 
of Biological Chemistry. 
NMR and ESR spectroscopies have conventionally been common methods for 
studying the fluidity of cellular and viral membranes33,34. NMR provides membrane 
information in a label-free fashion35–38, while ESR relies on spin probes covalently 
linked to specific target lipids39–41. Recently, several optical tools have been 
developed to probe membrane fluidity spatially resolved using smaller sample 
quantities. These methods were mostly based on fluorescence and included Förster 
Resonance Energy Transfer (FRET)42,43, Fluorescence Correlation Spectroscopy 
(FCS)44, Fluorescence Recovery after Photobleaching (FRAP)45, Fluorescence 
Anisotropy46 and Generalized Polarization (GP) of the Laurdan probe (Figure 
1.3)47,48. Some of these techniques can – in principle – be implemented on the single-
cell or even -virus level. However, utilizing them on a single virus particle whose 
dimensions are significantly below the diffraction limit is difficult due to a variety 
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of reasons including the limited number of dyes, their limited photostability which 
results in blinking and bleaching, their relatively low intrinsic intensities and, for 
some techniques, the inability to resolve individual moving dyes. 
1.4 The Relationship between Viral Membrane Composition, Fluidity and 
Infectivity 
It is becoming increasingly clear that the host-derived membrane of an enveloped 
virus contributes more to the infection mechanism than simply forming a molecular 
scaffold for the presentation of virus encoded membrane glycoproteins. Different 
lipids have been shown to play a role in virion capture and uptake through their 
interactions with corresponding receptors on the host cell surface. These 
multivalent interactions stabilize virus – cell interactions and, thus, induce 
subsequent virus-induced cellular processes. Phosphatidylserine (PS), for instance, 
has been shown to facilitate apoptotic mimicry and enhance glycoprotein-
independent uptake of Vaccinia49, Ebola50 and Dengue viruses51. PS is also a cofactor 
in infectivity of human immunodeficiency virus (HIV) in monocytic cells52. It has 
been shown that blocking PS in the viral membrane using Annexin V significantly 
inhibits the infection of monocytic cells, as shown in Figure 1.4. Glycosphingolipids 
(GSLs) are another important class of lipids that mediate interactions between virus 
particles and host cells. GSLs enable the glycoprotein-independent binding of HIV-
1 particles to mature dendritic cells (mDCs)4,5,53,54, and they have been indicated to 
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trigger the segregation of HIV-1 particles in non-lysosomal plasma membrane 
invaginations55,56. For instance, it has been shown that increasing the GM1 and GM3 
contents of HIV-1 directly enhances the capture of the virus particles by mature 
dendritic cells (mDCs), as shown in Figure 1.54. The functionality of GSLs is, 
however, not limited to HIV-1, instead GSLs act as attachment and entry factors for 
a diverse group of viruses57–62. All of the examples above corroborate the hypothesis 
that lipids contribute significantly to mediating virus – host-cell interactions, and 
this realization has motivated great interest in a quantitative analysis of viral 
lipidome to identify potential diagnostic and therapeutic targets63,64. 
 
Figure 1.4 Annexin V inhibits infection of monocytes/macrophages. (a) Jurkat T cells and U937 
monocytic cells were infected with HXB.2 in the presence or absence of 0.1 μM annexin V. Virus 
replication was monitored by RT assays 6 days postinfection. (b) THP-1 monocytic cell line was 
infected with HXB.2 in the presence of varying concentrations of annexin V. Virus replication was 
monitored on day 8 postinfection. Reprinted with permission from ref. 50. © 2003 American 
Association of Immunologists. 
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Figure 1.5 Capture of HIVLai enriched with GM3 or GM1 by mDCs was analyzed by detecting p24gag 
content in cell lysates by ELISA. Values represent the average from three donors and are reported as 
fold enhancement relative to mock-treated virus, ±SEM, *P < 0.05, **P < 0.001, one-sample t test. 
Reprinted with permission from ref. 4. © 2012 The National Academy of Sciences of the United States 
of America. 
The HIV virus preferentially buds from cholesterol (chol) enriched regions, so-called 
lipid rafts, whose composition determines viral membrane properties10. In a series 
of classic experiments Aloia et al. quantified the lipid composition and fluidity of 
HIV-1 and HIV-2 membranes and found that the chol to phospholipid ratio 
determines the phase of the viral membrane6,8. Subsequent studies with different 
methodologies also confirmed that the HIV membrane fluidity strongly depends on 
its chol content65,66. Importantly, extraction of chol from the membrane and the 
associated change in membrane fluidity result in a reduction of viral infectivity 
(Figure 1.6)7,65–67. Given this functional relationship, the ability to measure the viral 
chol content, its impact on membrane fluidity, ideally on the single-virus level, and 
its ties with other virological properties such as particle trafficking, Env protein 
density, maturation and dynamics68–71 are of great current interest in virology72.   
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Figure 1.6 Infectivity level determined for untreated, cyclodextrin (CD)-treated and chol-repleted 
HIV-1 on MT2 cells. Reprinted from ref. 64. © 2002 Lippincott Williams & Wilkins. 
1.5 The Importance of Small Sample and Single-Virus Characterization 
ESI-MS is a powerful analytical tool that has become the method of choice in 
quantitative lipidomics21,22,73. However, even for ESI-MS the quantification of viral 
lipids can pose significant challenges due to the need for adequate mass standards11 
and the relatively low physiological concentrations of most virus particles. In the 
case of HIV-1, for instance, the virus concentration is only ~106 particles/mL of blood 
at the time of seroconversion, which provides at best ~1.3×10-12 moles of total lipid 
per mL74. Considering additional losses during virus isolation and lipid extraction, 
sample quantities in the picomole range or above, as is required for state-of-the-art 
MS-based approaches22, are difficult to obtain especially for non-abundant lipids. 
Sample quantities are less of a concern for virus samples propagated in vitro in cell 
cultures where arbitrary amounts of virus can be generated. However, the 
clarification of important human health related questions, such as the role of 
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specific lipids in in-vivo virulence, require the ability to quantify relative 
concentrations of specific lipid species from patient-isolated samples. 
The ESR and NMR sample requirements are cumbersome, as well, for viral 
membrane studies where sample amounts are often limited (particularly in patient 
samples)74. Despite their versatility and accuracy, both NMR and ESR suffer from 
the need for large sample quantities, which typically lie in the milligram range37,40. 
Furthermore, considering that HIV is known to lead to abnormal cellular membrane 
compositions in patients75, the ability to obtain information about viral membrane 
chol content and fluidity in patient-derived samples is necessary to investigate their 
importance in the clinical setting and designing personalized medicine. 
1.6 Plasmon Coupling Microscopy 
Plasmonic NPs have unique optical properties12,76–78 that greatly aid the 
quantification of NP binding. The optical properties of noble metal NPs are 
determined by coherent conduction band electron density oscillations, so-called 
localized surface plasmon resonances (LSPRs)79,80 that give rise to large scattering 
cross-sections at resonant excitation76,81,82. In addition, the distance-dependent 
electromagnetic interactions (plasmon coupling) between these NPs causes a red-
shift in their scattering spectra which provides another variable that can be used in 
biological imaging applications83,84.  
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The electron density oscillation of metal NPs, in the first approximation, results in 
the formation of a dipole79,85. This approximation makes sense if the particle size is 
small enough (below 50 nm) that the higher order modes are negligible. Considering 
this approximation, the polarizability, α, of an NP with radius 𝑅𝑃 can be calculated 
using the following equation86: 
𝛼 = 4𝜋𝜖0𝑅𝑃
𝜖(𝜔)−𝜀𝑚
𝜖(𝜔)+2𝜀𝑚
  1.2  
where ε and εm are the dielectric constants of the metal and the medium and ε0 is 
the permittivity of vacuum. Therefore, the resonance condition is given by ε(ω)= 
ε1(ω)+ iε2(ω)=-2εm. εm is positive for materials such as air, water, etc. Consequently, 
the real part of the dielectric function for the NP needs to be negative to satisfy the 
resonance condition. This is a property that can only be satisfied by conductive NPs, 
such as gold and silver, in the visible range of the light. The high scattering cross 
section of the metallic NPs is, therefore, due to their special dielectric function given 
by the Drude model87. Accordingly, silver NPs have a higher polarizability than gold 
NPs and therefore a higher scattering cross section88–90. 
As mentioned earlier, another interesting property of plasmonic NPs is that their 
electromagnetic fields begin to interact when they are brought into close proximity 
(lower than a particle diameter separation). This gives them a pair polarizability 
which shift the plasmon resonance to lower energies. Assuming each particle 
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behaves like a dipole, the scattering cross section of the coupled dimer is 
proportional to the square of the pair polarizability, Ʌ91: 
  1.3 
where R is the interparticle distance. The electromagnetic interaction between two 
metallic NPs, therefore, causes a red-shift in the plasmon resonance wavelength. 
The dependency of the resonance wavelength, λ, on the interparticle separation was 
found empirically to follow an exponential trend as follows92: 
λ(L) = 𝐴 𝑒−
𝐿
𝐷 + 𝐶  1.4 
where A, C and D are parameters related to the size and material of the NPs. This 
property of the metallic nanoparticles can be used for measuring the density of 
biomolecules on biological membranes by measuring the scattering spectra and 
finding the resonance wavelengths93–96. Consequently, plasmon coupling has been 
utilized as analytical tool to probe the spatial clustering of nanoparticle labeled 
cellular surface receptors, as shown in Figure 1.797, to monitor  nanoparticle 
uptake93,98, and to study the enzymatic cleavage of DNA or proteins tethered 
between nanoparticles84,91,94,99,100. 
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Figure 1.7 Gold NPs used as labels for cell surface receptor density measurement. As the two receptors 
cluster, the resonance wavelength of the gold NP dimer increases. Reprinted from ref. 96. © 2008 
American Chemical Society. 
Polarization anisotropy is another quantity that can be measured experimentally in 
order to quantify the orientation and interparticle distance of the NP clusters and 
obtain information about the underlying substrate such as a biological membrane101. 
Polarization anisotropy, r, is defined based on the longitudinal and lateral scattering 
cross sections of the dimer or cluster of NPs through the following equation102: 
𝑟 =
𝐶𝑠𝑐𝑎𝑡 ∥−𝐶𝑠𝑐𝑎𝑡 ⊥
𝐶𝑠𝑐𝑎𝑡 ∥+ 𝐶𝑠𝑐𝑎𝑡 ⊥
  1.5 
where 𝐶𝑠𝑐𝑎𝑡 ∥ is the scattering cross section parallel and 𝐶𝑠𝑐𝑎𝑡 ⊥ the scattering cross 
section perpendicular to the original longitudinal axis. Assuming an incident light 
with fixed polarization or unpolarized, the polarization anisotropy depends on both 
the interparticle separation and the orientation of the long axis of a dimer or cluster 
of NPs, as both of these parameters affect the scattering cross sections in two 
orthogonal directions. Therefore, this quantity can be used for time-resolved 
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measurement of the rotational and translational diffusion of NPs on biological 
membranes. 
1.7 The Scope and Organization of this Dissertation 
This dissertation describes the basics of the development of two microscopy 
techniques designed and optimized specifically for quantification of lipid contents 
and fluidity of viral membranes. These techniques are based on plasmonic NP labels, 
plasmon coupling microscopy and polarization anisotropy tracking. In chapter 2, we 
demonstrate that the combination of the plasmon resonance intensity and 
wavelength, Iscat and λres, into one metric facilitates the quantification of NP-labeled 
target lipids in viral membranes103. The peak scattering intensity, Iscat, of individual 
virus particles is – in first approximation – proportional to the number of bound NP 
labels, and the LSPR wavelength, λres, of the bound NPs encodes information about 
the NP density, ρ, on the viral membrane. The plasmons in close-by nanoparticles 
couple88,104–106, and, as a consequence, λres red-shifts with decreasing interparticle 
separation83,89,92,107. With growing ρ, the average separation between the NP labels 
decreases, which results in measurable changes in the scattering spectra. We apply 
this technique to characterize the content of PS and the model GSL, GM1, in the 
membrane of HIV-1 and Ebola virus-like-particles (VLPs). The compositions of these 
VLPs are believed to closely mimic those of the corresponding infectious virus 
particles due to identical assembly and budding mechanisms108. The extraordinary 
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brightness of NPs facilitates the monitoring of lipid labeling for many individual 
VLPs in parallel, in a darkfield microscope. Characterizing lipid contents in a 
massively parallel single virus particle assay has the advantage that the necessary 
sample quantity is no longer determined by the sensitivity of the detector, losses 
during lipid extraction, or other experimental considerations, but only by the 
number of virus particles required to adequately sample the ensemble. After 
describing the technique development and representing our results in chapter 2, we 
will report the use of our technique by other virology researchers in their analyses 
of HIV-2 and MLV particles.109,110 
In chapter 3, we set out to avoid some of the limitations associated with monitoring 
membrane fluidities of single virus particles with fluorescence by replacing the 
fluorescent labels of membrane lipids with non-blinking and non-bleaching noble 
metal NPs. The rationale for our approach is that a polarizable metal NP interacts 
with an image charge in the VLP to which it is bound and that this interaction results 
in a net polarization of the scattered light111. Furthermore, the nanoscale 
confinement of two or more NPs on an individual virus particle with a typical 
diameter of 150 nm induces distance-dependent plasmon coupling between the NP 
labels, which can further enhance the light polarization. All of these electromagnetic 
interactions are orientation-dependent and modulate the far-field response of the 
labels89,101 and, thus, make it possible to detect NP displacements on the membrane. 
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The diffusion of NPs on the virus surface is, therefore, expected to induce 
fluctuations in the polarization of the scattered light. We introduce plasmonic 
polarization fluctuation tracking microscopy (PFTM) to quantify these fluctuations 
for individual HIV-1 VLPs before and after chol extraction at different temperatures 
to probe the effect of chol on the membrane fluidity of individual VLPs. Finally, in 
chapter 4, the future directions of the developed techniques will be proposed. 
This dissertation includes material from one publication by the author. Chapter 2 is 
reproduced from reference 103, coauthored with Xinwei Yu, Hisashi Akiyama, 
Caitlin Miller, Ethan Edmans, Suryaram Gummuluru and Björn Reinhard, 
reproduced with permission, © 2014 John Wiley and Sons. Chapter 3 is based on 
unpublished work that is in preparation for publication. The material in chapter 3 is 
produced in collaboration with David Stelter and Tom Keyes, who performed 
Molecular Dynamics simulations, Crystal Wong and Hisashi Akiyama who 
contributed in experiments and sample preparation and Suryaram Gummuluru and 
Björn Reinhard who contributed expertise and supervision.  
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Chapter 2 QUANTIFYING LIPID CONTENTS IN ENVELOPED VIRUS 
PARTICLES WITH PLASMONIC NANOPARTICLES 
PS and GM1 are two host-derived lipids in the membrane of enveloped virus particles 
that are known to contribute to virus attachment, uptake, and ultimately 
dissemination. The precise understanding of the roles that these lipids play on the 
surface of virus particles requires novel methods for quantifying their 
concentrations in the viral membrane. In this chapter, a gold NP-based binding 
assay for probing relative PS and GM1 lipid concentrations in the outer leaflet of 
different virus-like particles (VLPs) using sample sizes of less than 3×106 particles is 
introduced. The assay evaluates both scattering intensity and resonance wavelength 
and determines relative NP densities through plasmon coupling as a measure for 
the target lipid concentrations in the NP-labeled VLP membrane. The performed 
studies reveal significant differences in the membrane of HIV-1 and Ebola VLPs that 
assemble at different intracellular sites and pave the way to an optical quantification 
of lipid concentration in virus particles at physiological titers. In addition, this 
technique was used in other applications to improve the understanding of the 
relationship between the membrane PS lipid and the infectivity of HIV-2 and MLV. 
2.1 Density-Dependent Spectral Response of Gold Nanoparticle Labels 
The quantification of NP binding in an all-optical fashion requires a correlation of 
the NP signal, given by the peak scattering intensity, Iscat, and the plasmon 
21 
 
resonance wavelength, λres, with the concentration of membrane-bound NPs. In the 
first step of our analysis we set out to verify this relationship through rigorous 
electromagnetic finite-difference time-domain (FDTD) simulations (for details see 
Materials and Methods section). We simulated the spectral response of gold NPs 
bound to a 150 nm diameter dielectric sphere with a refractive index of nr = 1.500, 
which resembles the VLP – or complete virus particle for that manner – as a function 
of NP surface density. The latter is defined as ρ = m/A, where m is the number of 
membrane-bound NPs and A is the surface area of the virus particle. Up to m = 20 
NPs were distributed across the surface in a random fashion (see Materials and 
Methods section) with at least l = 25 different configurations for each m. Figure 2.1a 
illustrates schematically three of the investigated structures. The simulations 
assumed plane wave excitation at an angle of incidence of φ = 60° and were averaged 
over two orthogonal polarizations as indicated to emulate unpolarized white light 
excitation through a darkfield condenser. The peak positions of the scattering 
spectra for different m,l configurations are summarized in Figure 2.1b. The average 
spectra for each m are included as solid lines. In Figure 2.1c we plot the resulting 
average peak plasmon resonance wavelength ?̅?res ± std as function of m (and ρ).  The 
fitted resonance wavelengths for the different m,l configurations have some spread 
since random morphological differences impact the electromagnetic coupling 
between the NPs, but  ?̅?res shows a clear continuous red-shift as function of m. The 
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simulations indicate an average increase in ?̅?res of ~24 nm going from m = 1 to m = 
20. This red-shift is consistent with an increasing plasmon coupling due to 
decreasing average interparticle separations as m grows. The slope of the ?̅?res(m) 
graph is steepest for small m (or ρ) and then levels off with increasing m. The 
electromagnetic coupling does not continue to intensify in larger NP clusters of 
random geometry as plasmon coupling is a nearest neighbor effect. Figure 2.1d 
contains a plot of the average peak scattering intensity, 𝐼s̅cat ± std as function of m 
and ρ. 𝐼s̅cat increases approximately 26-fold between m = 1 and 20. Interestingly, the 
increase in 𝐼s̅cat is weaker for the m-range in which ?̅?res increases the most. This 
behavior indicates that the fraction of the incident power localized in the near-field 
is larger for smaller m. For larger m the scattering into the far-field dominates.  
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Figure 2.1 Simulated scattering spectra of gold NP labeled VLPs. a) Schematics of three random 
configurations of gold NP binding to VLPs. b) Simulated peak intensity and wavelength as function of 
the number of bound NPs, m. Solid lines show the average spectra calculated from 25 configurations. 
The numbers, 1-3, correspond to the structures shown in (a). c) Average peak wavelength as a function 
of bound NP density, ρ. d) Average peak scattering intensity as a function of ρ. Standard deviations are 
included as error bars. 
 
 
2.2 HIV-1 VLP Panel with Different Membrane Origins  
We used a test panel of four different enhanced green fluorescent protein (eGFP) 
tagged HIV-1 Gag-derived VLPs in this study. All VLPs were produced in vitro upon 
transient transfection of HEK 293T cells and had an average hydrodynamic diameter 
of ~160 nm (Figure 2.2).  
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Figure 2.2 Size distributions of HIV-1 and EBOV VLPs and liposomes used in this work obtained by 
DLS. Size distributions of a) HIV-1 VLPs, b) EBOV VLPs, c) liposomes with PS content as indicated, 
and d) liposomes with GM1 content as indicated. 
 
Our VLP panel included WT VLPs, VLPs generated in 1-phenyl-2-decanoylamino-3-
morpholino-1-propanol (PDMP)-treated host cells (PDMP VLPs), and VLPs derived 
from two Gag mutants: 29/31KE and ΔMA. PDMP inhibits GSL synthesis112 in VLP-
producing cells, so VLPs derived from PDMP-treated cells contain lower amounts 
of GSLs53. Note that 29/31KE Gag-eGFP and ΔMA Gag-eGFP contain mutations in 
the matrix (MA) protein component of Gag and have been shown by us and others 
to result in an alteration of VLP and infectious virus assembly sites.113–115 In 29/31KE 
Gag-eGFP, two positively charged lysines at positions 29 and 31 have been replaced 
with acidic glutamates, while ΔMA Gag-eGFP contains an in-frame deletion 
between amino acids 15 through 99 that alters plasma membrane targeting 
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specificity of Gag. Mutations in the matrix protein interfere with the ability of Gag 
to properly assemble at the cytoplasmic side of the plasma membrane, thus resulting 
in assembly of these mutant VLPs at intracellular membranes.114–116 This is illustrated 
in Figure 2.3a-c which shows the intracellular distribution of WT, ΔMA, and 29/31KE 
Gag-eGFP proteins in HEK 293T cells, similar to the results that we have shown 
before.115 While WT Gag-eGFP is preferentially associated with the plasma 
membrane (Figure 2.3a), ΔMA Gag-eGFP and 29/31KE Gag-eGFP are associated with 
diverse intracellular endocytic compartments (Figure 2.3a and c) that are invariably 
CD63 and lamp1 positive.114,117 The differences in intracellular spatial distribution of 
wild-type and mutant Gag-eGFP proteins are consistent with a differential budding 
phenotype of mutant Gags (ΔMA and 29/31KE) from different intracellular 
membranes. The different budding sites have direct influence on the capture of the 
VLPs by mDCs. The capture efficiencies of ΔMA and 29/31KE VLPs by mDCs are 
significantly lower than that observed for WT VLPs (Figure 2.3d). VLP binding to 
mDCs has been shown to be mediated by interactions between GSLs (in particular 
GM1 and GM3) on VLPs and CD169 on mDCs.4,5 The observed decrease in capture for 
the Gag mutants, ΔMA and 29/31KE, is consistent with a decrease of these lipid 
species in the VLP membranes.115 Similarly, previous studies have shown that VLPs 
derived from PDMP-treated host cells also show reduced capture by mDCs due to 
decreased GSL content in VLPs.118 Given these ostensible differences in their 
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membrane composition, WT, ΔMA, 29/31KE, and PDMP VLPs form a pertinent test 
panel for the development and validation of the proposed plasmonic NP based assay.  
 
Figure 2.3 Mutations in the matrix domain of the Gag redirect the formation of VLPs from plasma 
membrane to intracellular compartments.  Fluorescence images of HEK293T cells 1 day post 
transfection with a) WT Gag-eGFP, b) ΔMA Gag-eGFP and c) 29/31KE Gag-eGFP expression plasmids. 
Plasma membrane (GM1) and nucleus were stained in red and blue, respectively. In (a) WT Gag-eGFP 
colocalizes with the plasma membrane where WT VLPs assemble. In contrast, ΔMA and 29/31KE Gag-
eGFP in (b) and (c) are associated with intracellular compartments. d) Relative capture of WT, ΔMA 
and 29/31KE VLPs by mDCs. 
 
2.3 PS and GM1 Labeling with Gold NPs  
The Gag VLPs were labeled using annexin V (AnxV) and cholera toxin B (CTB) as 
highly specific recognition elements for PS and GM1, respectively,119,120 in 
combination with established biotin-Neutravidin binding chemistries (Figure 
2.4a).84 After tethering biotins to the VLP surface using AnxV or CTB, biotinylated 
gold NPs were bound using the tetrameric Neutravidin protein as linker. Under 
otherwise identical experimental conditions (ligand type, ligand concentration and 
incubation time), the average number of bound gold NPs in this labeling approach 
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is determined by the surface concentration of the targeted lipid as this quantity 
determines the total number of biotins on the VLP surface. Figure 2.4b shows a 
transmission electron microscopy (TEM) image of OsO4-fixed and negatively-
stained WT VLPs after labeling with gold NPs. The NPs are clearly discernible due 
to their large contrast. Additional TEM images as well as fluorescence-correlated 
scanning electron microscopic (SEM) images are provided in Figure 2.5.  We 
characterized the average number of bound NPs for selected lipid-VLP 
combinations (GM1-WT; PS-WT; PS-29/31KE) as well as for a control (missing 
required lipid-binding ligand, AnxV and CTB) in the SEM. The resulting relative 
labeling efficiencies are plotted in Figure 2.4c. The SEM data reveal a lower 
concentration of GM1 than PS in WT VLPs and a lower PS content in 29/31KE VLPs 
than in WT VLPs.  
Our SEM and TEM studies validate that our NP labeling strategy was successful. A 
detailed quantitative analysis of NP binding is, however, challenging via electron 
microscopy for multiple reasons. First, it requires the analysis of hydrated VLPs to 
retain the structural integrity and labeling of the VLPs. Furthermore, due to the 
large magnification required to count NP binding in the electron microscope, it is 
very time-consuming to gather information from statistically significant sample 
sizes in both SEM and TEM. Our aim was to avoid these complications entirely by 
28 
 
developing an uncomplicated optical approach for monitoring NP labeling of 
hydrated VLPs based on multispectral imaging. 
 
Figure 2.4 NP labeling strategy for PS and GM1. a) PS or GM1 are labeled using AnxV or CTB in 
combination with Biotin-Neutravidin binding chemistries. b) TEM images of fixed and negatively-
stained VLPs after NP binding to PS.  Scale bars are 40 nm. c) Relative Labeling efficiencies for 
different lipid-VLP combinations: PS-WT; PS-29/31KE, GM1-WT and control (lacking AnxV and CTB). 
 
Figure 2.5 a) SEM images of WT VLPs with gold NPs specifically targeted to PS lipid. VLPs were located 
on the substrate in the fluorescence microscope using their eGFP signal and an SEM locator grid was 
used to find them back in SEM.  Scale bars: 100 nm. b) TEM images of gold NPs bound on WT VLPs 
with PS lipid as the target. The samples were fixed with glutaraldehyde and OsO4 and negatively 
stained with sodium phosphotungstate. Some structural distortions can be observed in the VLPs due 
to drying process, which may have caused some GNPs to detach from their original position on the 
VLPs. Scale bars: 100 nm. 
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2.4 Multispectral Characterization of VLP Labeling  
The optical set-up used in this work (Figure 2.6a) was designed to facilitate the 
acquisition of both fluorescence and scattering images (Figure 2.6b). We found that 
the scattering spectra of individual NP labeled VLPs obtained through multispectral 
imaging (see Materials and Methods section for details) reproduce full spectra 
acquired with a conventional imaging spectrometer very well (Figure 2.6c). At the 
same time, the multispectral imaging provides the ability to acquire spectral 
information from all of the VLPs in the field of view in a short time without the need 
of raster-scanning the field of view. We used a 60x oil objective in our studies and 
routinely acquired spectral data of ~100 VLPs in a field of view of 75 by 75 μm2 within 
100 seconds. By translating the stage and recording data from different areas of the 
substrate, we collected the scattering spectra of hundreds of VLPs per sample within 
a few minutes. 
The second derivative of the single VLP spectra provided a quantifiable measure to 
determine whether a VLP was labeled.  We only included spectra that showed a clear 
plasmon resonance peak, defined by a threshold of the second derivative of ≤ -2 (see 
Materials and Methods section) and determined the fraction, F, of labeled VLPs in 
a sample. In Figure 2.6d, we plot the F values for the following lipid-VLP 
combinations: PS-WT; PS-29/31KE; GM1-WT. The F values from the multispectral 
analysis reproduce the relative NP labeling efficiencies obtained through SEM in 
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Figure 2.4c for the same lipid-VLP combinations. The good agreement confirms that 
the optical F value increases with growing number of gold NPs per VLP. 
 
Figure 2.6 Optical set-up for correlated fluorescence / multispectral darkfield imaging. a) Scheme of 
the optical set-up to characterize NP labeled VLPs (inset). 1-Tungsten lamp, 2-Filter wheel, 3-
Darkfield condenser, 4-Mercury lamp, 5-60x oil objective, 6-Fluorescence filter set, 7-EMCCD. b)  
Scattering (left) and fluorescence (right) image for WT VLP labeled for PS with NPs. A set of 9 
scattering images in the range between 530 to 600 nm were recorded. Inset shows fitted point-spread-
function for one scatterer. c) Comparison of spectra obtained through multispectral analysis 
(continuous lines) and imaging spectrometer (small markers) for an individual VLP with low (red, 
bottom) and high (blue, top) NP coverage. Insets show the corresponding scattering images. d) The 
binding probability, F, obtained through three or more optical measurements of three different 
samples. Error bars indicate standard deviations. 
 
2.5 Calibration of Multispectral Imaging with Liposomes  
The multispectral imaging approach measures the peak scattering intensity, Iscat, 
and the resonance wavelength of NP labels, λres. These values are defined through 
the maxima in the scattering spectra of individual VLPs obtained via multispectral 
imaging. Both observables are functions of the NP surface density on the VLPs, ρ. 
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The conversion of Iscat and λres measurements into a concentration of the targeted 
lipid requires a calibration with a membrane system of known composition. To that 
end, we fabricated unilamellar liposomes of similar size as the VLPs with a varying 
PS or GM1 content between 0% and 20%. The liposomes were labeled using the 
experimental strategy described above for VLPs before they were immobilized on 
the surface of a rectangular glass capillary to acquire multispectral data. These 
spectra were then fitted to obtain Iscat and λres (see Materials and Methods section).  
Figure 2.7a shows scatter plots of Iscat versus λres for different liposome samples, each 
containing the data of >500 individual liposomes. The figure shows the distribution 
of single liposome measurements in the (Iscat, λres) plane as black markers and a fitted 
distribution function, P(Iscat, λres), as a heat map (see Materials and Methods 
section). P(Iscat, λres) describes the statistical weight of a specific Iscat, λres 
combination. Figure 5b contains the binding probability, F, for the same samples of 
Figure 2.7a. 
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Figure 2.7 Calibration of concentration-dependent optical NP response with liposomes. a) (Iscat, 
λres)  scatter plots for liposomes with varying PS (top row) or GM1 (bottom row) concentrations as 
specified after labeling with gold NPs. Data are plotted as black markers, and fitted distribution 
functions, P(Iscat, λres), are overlaid as color maps. The white dashed lines comprise the Iscat × λres, 
area, A90%, that contains 90% of the data points. Each plot contains 500-1500 liposomes in total. b) 
Fraction, F, of labeled liposomes as a function of PS (top) and GM1 (bottom) concentration. c) Plot of 
the spectral function B = F × A90%  for GM1 and PS. d) B versus F scatterplot for various liposome and 
VLP measurements. The data plotted in (a) – (c) were collected in three independent experiments. 
 
Figure 2.7a shows that Iscat increases and λres red-shifts with increasing target lipid 
composition, which is consistent with a growing number of bound NP labels. 
Electromagnetic simulations (Figure 2.1) confirm that binding of a few NPs onto a 
VLP induces sufficient electromagnetic coupling to shift the resonance wavelength. 
In a random binding process, short and long interparticle distances will be formed 
simultaneously on the VLPs to generate a broad range of different NP scattering 
responses. The experimentally observed spread in Figure 2.7a is again consistent 
with the prediction from electromagnetic simulations (Figure 2.1). Both the 
scattering intensity and the resonance wavelength distribution of NP labeled VLPs 
contain information about the number of bound labels and these parameters are not 
independent. Pearson correlation coefficients of Iscat and λres in the range between 
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0.4-0.6 (Figure 2.8) indicate correlated intensity and spectral changes. Instead of 
characterizing NP labeling in terms of two individual observables, we therefore 
chose to describe the labeling through the fitted P(Iscat, λres) distribution as a metric 
that depends on both Iscat and λres. As a reference value for comparing the width of 
different P(Iscat, λres) distributions, we calculated the area, A90%, in the Iscat, λres plane 
containing  ~90% of all measurements around the P(Iscat, λres) maximum. This value 
was normalized by dividing through the corresponding area of the Au NP monomer 
ensemble (F=1 and A90%=1, Figure 2.9). We found good reproducibility in obtaining 
F and A90% values, and independent experiments using the same VLP batch showed 
deviations in the B values of less than 1% (Figure 2.10). 
 
Figure 2.8 Pearson correlation coefficients for the (Iscat, λres) distributions of PS/GM1 measurements 
in VLPs and liposomes with varying PS or GM1 content. 
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Figure 2.9 The (Iscat, λres) distribution plot of a “single” gold NP (SGNP) population with F=1 and 
A90%=1. The data were obtained from three independent experiments using ssDNA-conjugated gold 
NPs (approximately 300 NPs per experiment) randomly bound onto a glass surface using a biotin-
Avidin binding chemistry. 
 
 
Figure 2.10 Reproducibility of A90% and F values between different runs of lipid labeling 
experiments.  (Iscat, λres) distribution plots for PS targeted WT VLPs from three experiments (Run #1 
– Run #3) are shown in the left three panels. The right two panels show the corresponding average 
values for A90% and F with their standard deviations as error bars. The average B value from these 
measurements equals to 4.72±0.02. 
 
F and A90% values are synergistic. At low NP labeling levels, when the contribution 
from plasmon coupling to the optical signal is negligible, F is more useful to 
distinguish different samples than A90%. This changes, however, for higher NP 
labeling levels where A90% can facilitate the differentiation between samples in 
which all VLPs are labeled. In this case, the major difference lies in the number of 
bound NPs per VLP and, thus, ρ.  To describe the NP labeling of VLPs over a broad 
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range of target lipid concentration with a single quantity, we introduced the overall 
binding parameter, B = F × A90%. Figure 5c plots the B values obtained for the 
investigated PS and GM1 liposomes as a function of lipid composition. The plotted 
data are averages of 3 independent experiments performed on specific batches of 
liposomes. The B values exhibit a linear increase with growing lipid concentration 
in the investigated concentration range as described by the following fit functions:  
[𝑃𝑆] = 𝑚𝑃𝑆𝐵 + 𝑏𝑃𝑆               2.1 
[𝐺𝑀1] = 𝑚𝐺𝑀1𝐵 + 𝑏𝐺𝑀1        2.2 
where 𝑚𝑃𝑆 = 2.18, 𝑚𝐺𝑀1 = 1.07, 𝑏𝑃𝑆 = -0.37, 𝑏𝐺𝑀1 = -0.83 and [𝑃𝑆] and [𝐺𝑀1] are in 
mol%. Figure 2.7d contains a plot of B vs. F for ~100 measurements of different types 
of liposomes and VLPs. This plot shows that B increases linearly as function of F due 
to negligible changes in A90%. However, for F > 0.8, the slope of B increases abruptly, 
indicative of the onset of plasmon coupling due to multiple NP binding events to 
one object. For F > 0.95, the B value becomes almost exclusively a function of A90%, 
as plasmon coupling dominates the B value in this range.  
2.6 Characterizing GM1 and PS Contents in the HIV-1 VLP Test Panel  
Figure 2.11a shows (Iscat, λres) scatter plots as well as fitted P(Iscat, λres) surfaces as color 
maps for the PS and GM1 labeled VLPs of our HIV-1 test panel. The F values for the 
HIV-1 VLPs as well as for a WT VLP negative control that lacked any AnxV or CTB 
treatment are plotted in Figure 2.11b. The GM1 labeled VLPs in Figure 2.11a have lower 
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intensities and more blue-shifted resonance wavelengths than their PS 
counterparts. This finding, together with the systematically lower F values in Figure 
2.11b, confirm that the HIV-1 VLP membrane contains significantly less GM1 than PS. 
To substantiate this observation and to quantify the PS and GM1 lipid concentrations, 
we determined B values based on the experimentally obtained F values and the 
width of the (Iscat, λres) distributions, quantified as A90%. Equations (1) and (2) were 
then applied to convert the B values into PS and GM1 concentrations. These values 
are summarized in Figure 2.11c. Interestingly, our results indicate differences not 
only between PS and GM1 but also between PS in different HIV-1 VLPs. A two sample 
t-test showed significant (p<0.05) differences between all the samples except for PS 
levels in PDMP and 29/31KE VLPs and GM1 levels in WT and ΔMA VLPs. 
We observed that the PS content in different batches of WT VLPs varied between 
5.5-10.1%. For the batch of VLPs used for obtaining the results displayed in Figure 
2.11, the PS content was determined as 9.5±1.0 mol%. These values are in good 
agreement with mass spectroscopic studies of in vitro propagated HIV-1 virus 
particles that reported PS contents in the range between 8.4% - 13.4%, depending 
on host cell and conditions10,11. Interestingly, the PS content in 29/31KE VLPs 
(1.7±0.4%) and PDMP VLPs (2.5±0.7%) are both significantly lower. The PS content 
in ΔMA VLPs with 7.2±1.2% is comparable to that in WT VLPs. In the case of GM1, 
we determined lipid contents of 1.3±0.6%, 0.03±0.04%, 0.5±0.4% and 0.3±0.1% for 
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WT, PDMP, ΔMA and 29/31KE HIV-1 VLPs, respectively. These concentrations are 
close to the detection limit of our assay and we conclude that the GM1 content in 
HIV-1 is low. The obtained data imply that the GM1 level is highest in WT VLPs and 
that it is decreased to less than 1 mol% in other mutants. 
 
Figure 2.11 Optical quantification of PS and GM1 contents in 4 different HIV-1 VLPs. a) Iscat versus 
λres, scatter plot after labeling PS (top row) and GM1 (bottom row) in (from left to right) WT, PDMP, 
ΔMA and 29/31KE VLPs. Each plot contains the data of 500-1500 VLPs obtained in 3 or more 
independent experiments with one batch of VLPs. Data are plotted as black markers and fitted 
distribution functions, P(Iscat, λres), are overlaid as color maps. b) F values for lipid-VLP 
combinations shown in (a) and a WT VLP negative control that lacked any AnxV or CTB treatment. c) 
PS and GM1 content determined with Eq. 1 and 2 from the data in (a) and (b). 
 
2.7 GM1 and PS Contents in WT and PDMP EBOV VP40-Derived VLPs  
We also applied the optical lipid quantification assay to Ebola virus (EBOV) matrix 
protein VP40-derived VLPs, produced in untreated HEK-293T cells (WT VLPs) or 
PDMP-treated cells (PDMP VLPs). The (Iscat, λres) scatter plot and F histograms are 
shown in Figure 12a and b.  Negative controls without AnxV and CTB confirmed that 
the binding was PS or GM1 specific (Figure 13). In analogy to our analysis of the HIV-
1 VLPs, we converted these raw data into PS and GM1 contents (Figure 12c). 
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Even though we anticipate that the derived lipid concentrations have a larger error 
for EBOV than HIV-1, as the calibration was derived for spherical particles whereas 
EBOV VP40 VLPs have a filamentous shape, they still provide valuable information 
about relative differences. We find that the gap between PS and GM1 content has 
significantly dropped in EBOV VP40 WT VLPs when compared to HIV-1 WT VLPs. 
The PS concentration is decreased, whereas the GM1 concentration is increased. We 
conclude that the lipid composition of WT VLPs of EBOV and HIV-1 show 
significant differences. The most important one (vide infra) is the increased GM1 
concentration in EBOV VP40-derived VLPs. The GM1 content is – as expected – 
decreased in EBOV PDMP VLPs. As in the case of HIV-1 VLPs, we find that PDMP 
treatment also decreases the PS concentration, albeit to a lesser degree.  
 
Figure 2.12 Optical quantification of PS and GM1 contents WT and PDMP EBOV VP40-derived VLPs. a) 
Iscat versus λres, scatter plot after labeling PS (top row) and GM1 (bottom row). Each plot contains 
the data of 500-700 VLPs obtained in 3 or more independent experiments. Data are plotted as black 
markers and fitted distribution functions, P(Iscat, λres), are overlaid as color maps. b) F values 
associated with the same measurements. c) PS and GM1 concentrations (in mol%) resulting from the 
optical measurements. 
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Figure 2.13 The (Iscat, λres) distribution plots for negative controls of the optical measurements of PS 
and GM1 lipid concentrations in HIV-1 and Ebola VLPs. 
 
2.8 Discussion of PS and GM1 Quantification in HIV-1 and Ebola VLPs  
Our NP-based lipid quantification reveals distinct PS contents in the membrane of 
HIV-1 VLPs budding from different cellular membranes. This experimental 
observation confirms measurable differences in the composition of cellular 
membranes. Consistent with previous studies that demonstrated an enrichment of 
PS in the plasma membrane,121 the PS concentration was at the highest 9.5±1.0% in 
membranes of WT HIV-1 Gag-eGFP VLPs that assemble and bud from the plasma 
membrane. Interestingly, ΔMA VLPs, that bud from intracellular membranes 
(Figure 2.3), exhibited a PS content of 7.2±1.2%. This concentration is only slightly 
lower than that of the WT VLPs. In contrast, 29/31KE VLP membranes had a 
substantially lower PS content of 1.7±0.4%. The striking differences in membrane 
composition between ΔMA and 29/31KE VLPs suggests different intracellular 
budding sites. The measured PS level of ΔMA VLPs is close to that of the 
endoplasmic reticulum (ER).116 Given the observed striking difference in PS content, 
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it is unlikely that 29/31KE VLPs also bud from the ER, instead, other budding sites, 
such as late endosomal membrane, seem more plausible.114 
Our measurements show clear differences in the GM1 content of WT EBOV and HIV-
1 VLPs. While both EBOV and HIV-1 are known to bud from GSL-enriched lipid rafts 
in the plasma membrane,11,122 there is experimental evidence for the existence of 
different sub-sets of lipid rafts that are selectively enriched in GM1 or GM3.123,124 The 
differences in GM1 content between EBOV and HIV-1 VLPs observed in this work is 
consistent with the previous findings that EBOV and HIV-1 bud from separate lipid 
raft microdomains.125 While EBOV VP40-derived VLPs preferentially bud from the 
GM1 enriched domains,122 HIV-1 Gag-eGFP VLPs assemble and bud from GM3 
enriched plasma membrane sites.4 The low GM1 content in HIV-1 VLPs may be the 
reason why GM1 is not as effective as GM3 in mediating the capture of HIV-1 particles 
by DCs,4 although CD169 is capable of binding to both GSLs equally well,5 Another 
surprising finding of our studies is that the PDMP treatment of host cells not only 
reduces the GM1 content in the VLP membranes derived from these cells, but also 
the PS content. Since PDMP VLPs still bud from the plasma membrane,118 this 
finding indicates that PDMP treatment of the host cell not only inhibits the GSL 
synthesis pathway, but also affects other cellular processes that lead to a 
concomitant reduction of PS in the VLP membrane.  
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2.9 Conclusion 
We have introduced a new optical assay for measuring the lipid contents in VLP and 
viral envelope membranes based on the spectral analysis of gold nano-label binding 
and plasmon coupling. In this work we used 3×106 VLPs per experiment, although 
data collection from ~103 VLPs was sufficient to determine the membrane content 
of the targeted lipids. The large excess of more than 3 orders of magnitude of VLPs 
was necessary to achieve a sufficient binding of VLPs to the glass surface of our 
optical instrument in an adequate amount of time. We envision that the required 
sample amount can be dramatically reduced by improving the handling of the 
sample using microfluidics.  
The NP-based approach only provides information about labeled lipid species and, 
thus, does not provide the same breadth of information as label-free techniques, 
such as MS. Nevertheless, the ability to quantify selected lipid species in an optical 
approach with very small virus samples will facilitate new applications. A 
monitoring of surface features of patient-isolated virus particles is thus now within 
reach, which will eventually result in a more complete molecular characterization 
of viral species in different individuals and at different stages of an infection. 
2.10 Applications of the Technique in Other Quantitative Analyses 
The plasmonics-based technique that we have developed for quantification of lipid 
contents of virus particles was used by virology researchers Kijewski et. al. and Ahi 
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et. al. in their researches on HIV-2 and MLV particles, respectively.109,110 In their 
study of HIV-2 particles, Kijewski et. al. found that the CD-169-dependent pathway 
of trans infection is not as significant as it is in the case of HIV-1. Consequently, they 
performed a lipidomics analysis to compare HIV-2 and HIV-1 particles, including 
the measurement of PS and GM1 lipid contents using our plasmonic NP-based 
technique. Despite the significant reduce in the capture of HIV-2 VLPs by mature 
DCs and THP-1/CD169 cells, we found non-significant difference in the PS and GM1 
contents measured for HIV-1 and HIV-2 particles. However, the GM3 level was found 
to be significantly lower in the HIV-2 VLPs explaining the lower capture. This 
finding was justified by observing different budding locations on the plasma 
membranes of HEK293T cells after their co-transfection with HIV-2 Gag-eGFP and 
HIV-1 Gag-mCherry expression plasmids.  
Ahi et. al. studied the interplay between MLV’s glycogag, serinc5 and surface 
glycoprotein and their effect on the virus entry and compared this effect with that 
of the Ebolavirus. In this study, considering the effect of different mutations on the 
TIM-1 receptor interaction of MLV particles, they hypothesized that the presence or 
absence of the glycogag in the expression plasmid of MLV may affect its final PS 
lipid content. Consequently, they utilized our technique to compare the PS contents 
of three types of MLV particles (with Ecotropic, Xenotropic or Ebolavirus 
glycoproteins) and their glycogag-lacking mutants. However, surprisingly, our 
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measurements showed no significant difference in the PS contents of these six MLV 
samples. 
2.11 Materials and Methods 
Electromagnetic Simulations: FDTD simulations were performed with the Lumerical 
Solutions 8.7.1 software package. The mesh size of these simulations was always 5 
nm. The substrate was chosen as glass with a refractive index of 1.517. Virus-like 
particles (VLPs) and liposome were emulated as dielectric beads with a diameter of 
150 nm and a refractive index of 1.500. The refractive index of the medium was set 
to 1.335. Gold NPs were assumed to be 40 nm in diameter and we used the gold 
dielectric function given by Johnson and Christy.126 The light source in these 
simulations was always a planar wave with a single wavelength. The angle of 
incidence was 60° and we averaged over two orthogonal polarizations. The 
simulations were performed for nine discrete wavelengths (corresponding to the 
center wavelength of the filters used in the multispectral imaging: 530 nm, 540 nm, 
546 nm, 550 nm, 555 nm, 560 nm, 570 nm, 580 nm, 600 nm). The detector in this 
simulation was a single planar far-field detector placed in the glass beneath the 
VLP/NP complex. The maximum possible number of NPs is 38 in the case of close 
packing. We distributed m NPs randomly over these coordinates. We considered m 
= 1 – 10, 15 and 20. For each m, 25 different unique random configurations were 
created. We kept a minimum spacing of 10 nm between the NPs. The NPs were 
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placed 5 nm away from the VLP surface, assuming a 5 nm thickness for the ssDNA 
shell on the NPs under experimental conditions.  
Liposomes Preparation: In the first step, lipids in a defined ratio were dissolved in 
chloroform. The lipid mix consisted of 1,2-dipalmitoleoyl-sn-glycero-3-
phosphocholine (DPPC), Cholesterol, 1,2-dioleoyl-sn-glycero-3-phospho-L-serine 
(DOPS) and ganglioside GM1, all purchased from Avanti Polar Lipids, Inc. The 
cholesterol concentration was kept constant at 45 mol%, 0.1% of which was 
fluorescently labeled with TopFluor. In the case of PS liposomes, the concentration 
of GM1 was fixed at 5%, while the concentration of DOPS was either 0, 5, 10 or 20%. 
The DPPC concentration of these liposomes was 50% 45, 40 and 30%. Similarly, in 
the case of GM1 liposomes, the concentration of DOPS was kept constant at 10%, and 
the concentration of GM1 was varied between 0, 0.5, 1, 3 and 10%. The DPPC 
concentration in the liposomes was accordingly 45, 44.5, 44, 42 and 35%. The total 
concentration of lipids in 150 µl of chloroform was 7 mM.  
The chloroform in the lipid solution was removed with a rotary evaporator 
connected to vacuum at room temperature. The flasks containing the lipids were 
left in vacuum overnight. Then, 1 mL of 20 mM HEPES buffer (pH=7) was added to 
each flask and it was sonicated in a bath sonicator for 60 min at room temperature. 
This colloid of synthesized liposomes was extruded through a 100 nm polycarbonate 
membrane 9 times while maintaining a temperature of 40˚C on a hot plate. The 
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liposomes were subsequently stored at 4˚C. Average size and concentration of the 
liposomes were measured through dynamic light scattering (DLS) with a Malvern 
ZetaSizer. Concentration was measured based on the count rates in dynamic light 
scattering tests on serial dilutions of the sample and using Concentration Utilities 
of ZetaSizer software. 
Preparation of Biotinylated Gold NPs: 40 nm gold NPs (from TedPella Inc.) were 
functionalized with single stranded DNA oligonucleotides using the method by Liu 
et al.127 The oligonucleotides HS-AAAAAAAAAACTCACGCTAC-GACTGACACC 
and HS-AAAAAAAAAAGACCTACTAAGACTACTACACAACCAGAGA-Biotin 
oligonucleotide were mixed in a 4:1 ratio. This mix was added to gold nanoparticle 
colloid in DDI water to yield a final concentration of 25 µM DNA and 1.5 nM 
nanoparticles in a total volume of 10 µl and incubated for 30 min at room 
temperature. The pH was then lowered to pH = 3 by adding 10 mM sodium citrate 
buffer in a negligible volume. The mix was incubated for another 30 min. After that, 
the gold nanoparticles were washed by repeated centrifugation (2,400 ×g, 10 min) 
and resuspension in 1.5 mL in DDI water. After the third washing step, the NPs were 
passed through a 0.22 µm syringe filter to remove any agglomerates or impurities. 
The particles were then collected by centrifugation at 2,200×g. The resulting DNA-
conjugated gold NP pellet was diluted with DDI water before 10x PBS was added to 
reach a final concentration of 0.15 nM NPs in 1x PBS. The volume of added PBS was 
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adjusted in experiments that required higher/lower concentrations. The 
concentration, size and zeta potential of the NPs were measured in 1x PBS buffer by 
UV-Vis spectrometer and Malvern ZetaSizer right before use.   
VLP/Liposome Functionalization: GM1 and PS in the VLP/Liposome membrane were 
functionalized with biotinylated Annexin V (Abcam) or cholera toxin subunit B (Life 
Sciences Inc.), respectively, using a 10000:1 ligand:VLP ratio. For this purpose, 107 
VLPs/liposomes in 0.5-2 µL of stock were added to 10 µL of 1x Annexin Binding Buffer 
(ABB: 10 mM HEPES pH = 7.4, 137 mM NaCl, 2.5 mM CaCl2) and 0.5 µg of AnxV or 
CTB was added and incubated for 30 min at room temperature. Then, an 8-fold 
excess of neutravidin (NTV, Thermoscientific Inc.) in PBS and 1% Bovine Serum 
Albumin (BSA) was added and incubated for 30 min at room temperature. 
Subsequently, the functionalized VLPs were purified from excess proteins in 
solution through ultracentrifugation (Beckman-Coulter Optima TLX) on 60% 
sucrose cushion (100k ×g, 30 min, 4˚C), followed by 24-48 h of dialysis against 1x 
ABB using a 100 nm pore size polycarbonate (PC) membrane in a micro-dialyzer 
(Harvard Apparatus Inc.) in an ice bath. Liposomes were purified by dialysis as 
described above. The functionalized VLPs/liposomes were diluted to 150 µL in ABB, 
and stored at 4˚C for experiments during the following week. This amount of 
functionalized VLPs/liposomes was enough for at least 3 optical measurements or 
5-10 electron microscopy samples. The Ebola VLPs were functionalized for PS and 
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GM1 lipids in a similar procedure, with the exception that a 200 nm PC membrane 
was used. 
Sample Preparation for Optical Measurements: The functionalized VLPs, in 50 µL 
ABB, were flushed into rectangular borosilicate capillaries (100 × 2 × 0.1 mm3, from 
Vitrocom), where they stuck non-specifically to the fused silica surface. Under 
typical experimental conditions, the VLPs were incubated until approx. 100 VLPs 
were bound in the field of view (75 µm×75 µm area of the image) to avoid 
interference between the individual VLPs (this step took normally around 30 min at 
4˚C). We used VLP samples with a concentration of 6x104 VLPs/μL and consumed a 
total of ~3x106 VLPs per experiment. After that, excess VLPs were removed by 
flushing the chamber with 1x ABB. The surface was then blocked by 10% BSA in 1x 
ABB for 2 hr at 4˚C. After washing the samples with 1%BSA in 1xPBS the samples 
were incubated with 0.1 mg/mL polyinosinic acid (PI) in 1%BSA/1xPBS for 30 min at 
room temperature. PI was subsequently removed by flushing the flow chamber with 
1%BSA in 1xPBS. In the next step, the immobilized VLPs were incubated with a 1.5 
nM solution of biotin-functionalized gold nanoparticle labels in 1x PBS for 15 min at 
room temperature. Unbound gold nanoparticles were flushed out with 1x PBS. In 
case of Ebola VLPs, anti-EBOV GP goat IgG (antibody against EBOV glycoprotein) 
in PBS was incubated after this step in the capillary for 15 min at room temperature, 
followed by 15 min incubation of anti-goat IgG-Alexa488 (from Life Sciences Inc.). 
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This procedure labeled the glycoproteins on the surface of the VLPs for VLP 
localization. The samples were then washed with PBS. After that, the samples were 
ready for optical characterization. 
EM Sample Preparation: Electron Microscopy samples were prepared similar to 
optical measurement samples, except the substrate was a 5 mm × 5 mm quartz chip 
for SEM samples and a 9-window SiN grid for TEM samples (from Ted Pella Inc.). 
Also, the EM samples went through fixation or negative staining or both after gold 
nanoparticles binding. For SEM samples, 20 µl of the functionalized VLP stock was 
initially incubated on a quartz chip for 1 hr at 4˚C. Then, the surface of the chip was 
flushed by pipetting 50 µL of ABB on the chip 3 times. Then, 10%BSA in ABB was 
incubated on the chip for 2 hr at 4˚C. The chip was subsequently washed with PBS 
3 times before 0.1 mg/mL PI in PBS was incubated on the sample for 30 min at room 
temperature. Then, the sample was washed with 1%BSA in 1x PBS and conjugated 
gold NPs in PBS were incubated on the substrate for 15 min at room temperature. 
Then the sample was washed again with PBS. NP-labeled VLP samples were 
incubated with 2.5% glutaraldehyde (Sigma-Aldrich) in 1x PBS for 30 min and 
subsequently with 1% OsO4 in PBS (50 mM salt) for 30 min at room temperature. 
The SEM samples were then washed with water and air dried. TEM samples went 
through a similar process on a SiN grid. The samples were stained with 1% sodium 
phosphotungstate in water (pH=7.4) for 30 seconds, blotted and then dried. 
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SEM and TEM Characterization: SEM samples were coated by a thin layer of Au/Pd 
using a sputter coater to provide conductivity. SEM imaging was performed on a 
Zeiss Supra 55 VP scanning electron microscope with 10 kV EHT. TEM imaging was 
performed by a JEOL JEM 2010 scope with 200 kV acceleration voltage. 
Multispectral Imaging (MSI) and Spectrometry: All imaging experiments were 
performed with an inverted microscope (Olympus IX71) equipped with an oil 
immersion darkfield condenser and 60x objective. For each field of view, nine 
monochromatic scattering images were recorded under darkfield illumination using 
10 nm bandpass filters with center wavelengths of 530, 540, 546, 550, 555, 560, 570, 
580, and 600 nm. In addition to the 9 scattering images, one fluorescence image 
(400/530 nm excitation/emission filters and a 470 nm dichroic) of the same field of 
view was recorded. Images were all recorded by an Andor iXon EMCCD camera with 
a 512×512 pixels detector. For scattering images we accumulated 10 acquisitions with 
an exposure time of 1 sec and electron multiplier setting of 10. For fluorescence 
measurements we used an exposure time of 0.1 sec and an electron multiplier setting 
of 100. The 60x objective had a variable numerical aperture (NA), so the scattering 
images were recorded with NA = 0.65 and the fluorescence images were recorded 
with NA = 1.25. Full spectra were recorded using a Shamrock spectrometer with a 
CCD detector connected to the same microscope setup. To account for the spectral 
profile of the Tungsten lamp used as excitation source MSI and spectral data were 
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corrected by dividing through the corresponding average scattering data obtained 
from unlabeled VLPs. 
Image Processing and Spectral Analysis: All image processing and data analysis was 
performed using a home-written Matlab code. The point-spread-function (PSF) of 
every VLP/liposome in monochromatic scattering images was fitted with a Gaussian 
function of the form: 
𝐺(𝑥, 𝑦) = 𝐴𝑒
−[
(𝑥−𝑥𝑜)
2
2𝜎𝑥
2 +
(𝑦−𝑦𝑜)
2
2𝜎𝑦
2 ]
+ 𝐵𝐺 , 2.3 
where xo and yo are the Gaussian peak position, σx and σy are the full width at half 
maximum of the Gaussian along x and y directions, A is the Gaussian amplitude, and 
BG is the background. After subtracting the background (BG), the integrated 
intensity of the PSF was taken as the scattering intensity of the VLP/liposome at that 
specific wavelength. Then, a white light correction was performed by dividing the 
intensities by the intensities of unlabeled VLPs (which we assumed to be whitelight 
scatterers) at the corresponding wavelengths. While the VLP spectrum was flat, 
binding of NPs led to an increase in intensity on one or more of the monitored 
wavelength channels.  
We only included VLPs in our analysis of (Iscat, λres) distribution plots and A90% 
calculations whose intensity was in the third quartile (or above) of the intensity 
distribution of the unlabeled VLPs in all of the monitored wavelength channels. For 
the VLPs/liposomes that passed the intensity threshold, a second order Gaussian 
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curve was fitted around the maximum-intensity wavelength and the second 
derivatives of the spectra at peak position were calculated. We chose a second order 
Gaussian fit function as the spectra showed some slight asymmetries. We included 
only VLPs with a second derivative at peak wavelength of -2 or lower (95% of the 
population of monomer NP labels passed this criterion) to further separate labeled 
from unlabeled VLPs. The fraction of labeled VLPs/liposomes defined the F value.  
Peak Scattering Intensity versus Resonance Wavelength (Iscat, λres) Plots and B Value 
Calculations: We plotted the peak scattering intensity (Iscat) versus resonance 
wavelength (λres) for all VLPs and then histogrammed the data. The bin size of the 
histogram was 5 on the wavelength axis from 530 nm to 600 nm, and 0.2 on the 
intensity axis from 0 to 5 in arbitrary units. A 3D surface was then fitted to this 
histogram. For this purpose, the data of the 3D histogram were imported to 
TableCurve 3D v4.0 software and a Chebyshev bivariate polynomial order 7 was 
fitted on the data. As a measure of the width of the peak intensity versus wavelength 
distribution, we calculated the area enclosed by the fit at a height corresponding to 
20% of the fitted surface peak. We found that this area enclosed 90%±7% of the 
measurements in all the samples, and we consequently refer to it as A90% throughout 
the text. The binding value, B, of each sample was calculated as B=F×A90%. The A90% 
value was set to 0 for samples with F ≤ 0.05. 
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Cells: Human DCs were derived from CD14+ peripheral blood monocytes, as described 
previously.53 DCs were matured with ultrapure E. coli K12 LPS (100 ng/mL; Invivogen) 
for 2 days prior to use. HEK293T (human kidney epithelial cell line) has been described 
previously.53  
Plasmids and VLPs generation: The expression plasmid, HIV-1 Gag-eGFP was provided 
by NIAID AIDS Reference and Reagent Program (ARRRP; contributed by Drs. Marilyn 
D. Resh and George Pavlakis). WT and PDMP HIV-1 VLPs were produced as previously 
described.118 Briefly, WT VLPs were synthesized by transfecting HEK 293T cells with a 
Gag-eGFP expression vector. For PDMP VLPs the host cells were treated with 10 µM 1-
phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP, Calbiochem) from 24 hr prior 
to transfection until harvesting VLPs to inhibit GSL synthesis in the host cell. The MA 
deficient (∆MA Gag-eGFP) or MA mutant (29/31KE Gag-eGFP) plasmids are isogenic to 
HIV-1 Gag-eGFP, except for the presence of the indicated in-frame deletion (aminoacid 
15 to 99) or point mutations (K29E and K31E) in the MA coding region as described 
previously.115 ΔMA and 29/31KE VLPs were generated via transient transfections of 
HEK293T cells with ΔMA and 29/31KE Gag-eGFP expression constructs, respectively.  
VLPs were purified and concentrated from culture supernatant through filtration and 
ultracentrifugation (24,000 rpm at 4˚C for 2 hr with a SW32Ti rotor, Beckman) on 20% 
sucrose cushion. The size and concentration of different stocks of VLPs were measured by 
Malvern ZetaSizer (Nano ZS90) and iZon’s qNano particle counter or p24gag ELISA assay.  
The plasmids expressing EBOV VP40 and glycoprotein, GP (Zaire) were obtained from 
Dr. Elke Mühlberger (BUSM). EBOV VP40 cDNA was PCR amplified and cloned in 
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frame to the C-terminus of β-lactamase in the expression plasmid pMM310.128 To make β-
lactamase containing EBOV VP40 derived VLPs, HEK293T cells were transiently co-
transfected with EBOV VP40-Blam and GP (2:1 molar sratio) expression constructs, as 
described previously.115 To deplete glycosphingolipids in VLPs, HEK293T cells were 
treated with PDMP (10 μM), prior to transfection until harvesting VLPs, as described 
previously.118 VLPs were harvested at 2 days post-transfection and centrifuged (300 x g, 5 
min) to clear debris. VLPs were concentrated over a 20% sucrose cushion by 
ultracentrifugation [24,000 rpm, 4°C for 2 hr with a SW32Ti rotor (Beckman)]. VLP pellet 
was resuspended in HeNa buffer (140 mM NaCl, 10 mM HEPES), aliquoted and stored at 
-80 °C. The concentrations and sizes of purified WT and PDMP Ebola VLPs were found 
by DLS similar to HIV-1 VLPs. 
Cellular Imaging: HEK293T cells, seeded on coverslips in 24-well tissue culture plates, 
were transfected with Gag-eGFP encoding plasmids by calcium phosphate. One day post 
transfection, cells were washed and fixed with 4% PFA. GM1 was visualized using Alexa 
594-conjugated cholera toxin subunit B (CTB) (10 µg/mL; Life Sciences Inc.) and nucleus 
was stained with DAPI (Sigma). Series of Z-section images were acquired using an 
Olympus IX70 microscope equipped for DeltaVision deconvolution (Applied Precision).  
Images were deconvoluted using the SoftWoRx software (Applied Precision). 
DC Capture Assay: Mature DCs (1x105) were incubated with VLPs (1 ng p24gag) for 1 hr 
at 37°C in complete RPMI media, washed 24x with PBS and analyzed for capture using 
FACS analysis as previously described.118 The assay was performed with mature DCs 
derived from four independent donors. 
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Chapter 3 Plasmonic Polarization Fluctuation Tracking Microscopy: A 
Technique for Measuring Viral Membrane Fluidity on the Single-Virus Level 
Viral membranes are nanomaterials whose fluidity depend on their composition, in 
particular the cholesterol (chol) content. As differences in the membrane 
composition of individual virus particles can lead to different intracellular fates, 
biophysical tools capable of probing the membrane fluidity on the single-virus level 
are required. In this manuscript, we demonstrate that fluctuations in the 
polarization of light scattered off gold or silver nanoparticle (NP) labeled virus-like-
particles (VLPs) encode information about the membrane fluidity of individual 
VLPs. We developed a plasmonic polarization fluctuation tracking microscopy 
(PFTM) which allowed, for the first time, the investigation of the effect of chol 
content on the membrane fluidity and its dependence on temperature on the single-
VLP level. Chol extraction studies with different methyl-β-cyclodextrin (MβCD) 
concentrations yielded a gradual, time-dependent decrease in polarization 
fluctuations as function of time. The rate of chol extraction for individual VLPs 
showed a broad spread, presumably due to differences in the membrane 
composition for the individual VLPs, and this heterogeneity increased with 
decreasing MβCD concentration.  
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3.1 In-silico validation and experimental implementation of PFTM 
To validate our hypothesis that the random diffusion of NPs tethered to a VLP 
generates a measurable optical signature, we simulated the polarization, P, of the 
light scattered off a VLP containing two randomly diffusing 40 nm silver NPs (SNPs) 
through FDTD method. We chose a VLP size of 150 nm as this corresponds to the 
average size of HIV-1 particles and we treated the virus as a dielectric particle of 
refractive index n = 1.5. P was calculated from the scattered light intensities with 
orthogonal polarizations, 𝐼∥ and 𝐼⊥, according to
101,129,130: 
𝑃 =
𝐼∥−𝐼⊥
𝐼∥+𝐼⊥
,  3.1 
The frame rate in our optical measurements was 500 frames per second (fps). 
Assuming a typical diffusion coefficient of 4 μm2/s for the SNP,131 its root mean 
square displacement (RMSD) is approximately 200 nm within 2 ms. Given this 
RMSD, each NP can reach almost any point on the virus surface between two 
subsequent frames in the case of random diffusion. A representative simulated 
polarization fluctuation trajectory (PFT) for this random diffusion is included in 
Figure .3 1a (blue line). The simulation predicts a rich P dynamics with P values in 
the range between -0.6 and 0.6. The P distribution is well fit by a single Gaussian as 
expected for a completely stochastic process.  
In our experiments, SNPs were attached to phosphatidylserine (PS) lipids in the 
membrane of VLPs via AnxV and NTV chemistry (Figure .3 1b,c).  Our experimental 
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set-up to monitor P was based on a dark-field microscope that records the light 
scattered from the NPs on two orthogonal polarization channels (Figure .3 1d). The 
sample was illuminated with a 100 W Tungsten lamp through a high numerical 
aperture (NA = 1.20) dark-field condenser. The scattered light was split according to 
polarization using a polarizing beam splitter and two images of the entire field of 
view (128 x 128 pixels = 62 x 62 μm2) with orthogonal polarizations were recorded on 
two separate EMCCD cameras with a frame rate of 500 fps. Each field of view 
contained approximately 50 individual VLPs under typical experimental conditions. 
The experimental  𝐼∥ and 𝐼⊥ values were determined by fitting the point-spread-
functions of the labeled VLPs to 3D-Gaussians and integrating the volumes under 
the surfaces. Intriguingly, while the simulations show a normal distribution within 
a P-range defined by the polarization anisotropy of a touching dimer, the 
experimental PFTs often show a behavior in which the polarization switches 
between only a few distinct P values. An exemplary experimental trajectory is shown 
in Figure 1e. The higher probability for a limited number of specific P values is 
indicative of the existence of favored geometric NP configurations. The behavior can 
be emulated in the simulation by applying an adequate P probability distribution 
(red lines in Figure 3.1a), and it reveals that the NP labeled lipids do not diffuse freely 
across the membrane but that their motion is hindered. The latter is not entirely 
unexpected since the viral membrane derives from mammalian host cells, which are 
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known to be compartmentalized132. Overall, our combined experimental and 
theoretical analysis confirms that P and its variance, Var(P) are useful quantities for 
characterizing the NP mobility on the membrane. 
 
Figure 3.1 Implementation of PFTM. (a) Simulated PFTs for two 40 nm SNPs on a 150 nm diameter 
virus particle with random motion (blue) and with two preferred geometric NP configurations (red) 
(right: geometric configurations corresponding to the two marked points in the PFT). (b) SNPs are 
tethered to phosphatidylserine in the VLP membrane through biotinylated-ssDNAs (ssDNA-Biotin) 
bound to the NPs and neutravidin (NTV) and annexin V (AnxV) chemistry. (c) Schematic illustration 
of SNP-labeled VLP structure with two different configurations. (d) The optical set-up used to record 
PFTs contains a tungsten lamp, dark-field condenser, 60x oil objective, polarizing beam-splitter and 
two CCD cameras. (e) Left: Exemplary experimental PFT and corresponding P histogram. Right: CCD 
images (7x7 pixels per VLP) of a SNP-labeled VLP in the 𝐼∥ and 𝐼⊥channels at two consecutive time 
points ti and ti+1 and their corresponding Gaussian fits. 
 
3.2 The effect of plasmon coupling in polarization fluctuations 
Some SNP-labeled VLPs (SNP-VLPs), despite containing multiple SNP labels, did 
not show significant P fluctuations. These VLPs contained NP agglomerates that did 
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not change their orientation and interparticle separation. To identify VLPs with 
mobile NP labels, which are of primary interest for characterizing membrane fluidity 
and how it is affected by chol, we compared the Var(P) of individual VLPs to that of 
immobilized isotropic polystyrene NPs (200 nm) with identical scattering 
intensities. Figure 3.2a shows the Var(P) of 250 individual polystyrene NPs at 
different incident light intensities as red markers. Figure 3.2a also contains the 
Var(P) for 500 NP-labeled VLPs as black circles.  
The number of SNPs per VLP was derived by comparison with the intensity of single 
SNPs immobilized on a substrate (Figure 3.3). We attached DNA-biotin conjugated 
silver and gold NPs (44 and 45 nm in average hydrodynamic diameter, respectively) 
to the glass substrate through BSA-biotin and NTV. Then their individual PFTs (160 
GNPs and 250 SNPs) were measured and their averaged total scattering intensities 
were calculated. The distributions of the scattering intensities for these populations 
of SNPs and GNPs are shown in supplementary Fig. 1. While the GNPs and SNPs 
have similar sizes, the scatteri ng intensities of the individual SNPs are 
significantly (p < 0.001) higher than that of the GNPs. This is due to the higher 
polarizability of silver compared with gold.  
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Figure 3.2 Plasmon Coupling between the SNPs enhances the P fluctuations. (a) Var(P) for SNP-
labelled VLPs (black circles) and 200 nm diameter polystyrene NPs (red x) as function of intensity. 
The inset shows transmission electron micrographs of VLPs with different numbers of bound SNPs; 
the length of the scale bar is 100 nm. The number of SNPs bound per VLP was determined by dividing 
the measured scattering intensity of individual SNP-VLPs through the average SNP intensity. The 
gray histogram shows the number of SNP-VLPs carrying a specific number of SNP labels (top x-axis). 
The fraction of SNP-VLP with Var(P) three standard deviations higher than the Var(P) of the 
polystyrene NPs with identical intensity is included as solid black lines. (b) Fluctuations of the total 
intensity, 𝐼𝑡, as function of time for an individual SNP (blue) and for an SNP-VLP with two SNPs 
(orange). (c)  P as function of 𝐼𝑡 for the two SNP-VLPs shown in (b). Only the SNP-VLP with 2 labels 
(orange) shows a correlation between P and 𝐼𝑡. (d) Comparison of the absolute value of the Pearson 
correlation coefficient, ρ, for SNP-VLPs with 1 and 2-3 SNPs. *** indicates a Student’s t-test p-value 
below 0.001. 
 
Figure 3.3 Single SNPs’ and GNPs’ scattering intensity distribution. SNPs have larger scattering cross 
sections. 
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The VLPs carried up to l = 13 SNP labels leading to a broad spread of the data along 
the intensity axis. The contribution of each NP label number to the total ensemble 
is included as gray histogram in Figure 3.2a. In the following data analysis, we only 
included measurements with average Var(P) values that were at least above the third 
standard deviation from the mean Var(P) for polystyrene NPs at each intensity. This 
fraction, which is included as solid black lines on the histogram in Figure 3.2a, 
increases through l = 1 - 3, and then gradually decreases with growing l. The non-
negligible fraction of VLPs above the threshold for l = 1 is caused by electromagnetic 
interactions between the SNP and a mirror dipole in the supporting dielectric VLP 
and, in addition, some asymmetry of the individual SNPs which are often not ideal 
spheres. The rotation of non-spherical SNPs leads to measurable P fluctuations 
(Figure 3.4). After obtaining the PFTs of individual SNPs as described in the previous 
section, we plotted their Var(P) versus average total scattering intensity so that we 
can compare them with the case where the SNPs are attached to the surface of VLPs 
(Figure 3.4a). 62% of the SNPs bound to VLPs were above the noise threshold 
defined by polystyrene NPs (i.e. 62% of the VLPs contained mobile SNP probes), 
compared to 29% of the SNPs attached to the glass substrate. The SNPs were 
attached to the glass surface through protein linkers, which resulted in some 
configurational freedom for the attached NPs. A fraction of SNPs has anisotropic 
shapes and therefore an intrinsic polarization anisotropy. The rotation of such 
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individual SNPs around the protein linkers that attach them to the substrate leads 
to fluctuations in the polarization of their scattered light and create Var(P) above 
the threshold. We independently investigated the shapes of the SNPs used in this 
work through SEM and found anisotropic particles, such as prism-shaped particles 
(Figure 3.4b) and other shapes. 
          
Figure 3.4 (a) Variance of PFTs recorded for SNPs bound to a glass substrate through BSA-biotin and 
NTV and SNP-VLPs. 62% of SNP-VLPs are above the minimum Var(P) threshold compared with 29% of 
the SNPs. (b) SEM images showing anisotropic SNPs. 
Importantly, as shown in Figures 3.2b,c (blue data) VLPs with a single SNP show 
only weak fluctuations in the total intensity, 𝐼𝑡 = 𝐼∥  +  𝐼⊥, and the fluctuations in P 
for individual SNPs were usually not accompanied by changes in 𝐼𝑡. Anisotropic 
SNPs have a preferred polarization axis and spherical NPs can acquire one through 
interaction with the dielectric support111,133, but importantly a rotation of their 
polarization axis only changes the distribution of the scattered light on the two 
detectors but not the intrinsic anisotropy itself.  In contrast, for an SNP dimer we 
typically observed correlated fluctuations in P and 𝐼𝑡 (see orange data in Figures 
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3.2b,c). The difference between monomers and dimers arises from the fact that in 
dimers (and larger clusters) changes in the inter-particle separation modulate the 
polarization anisotropy as well as the total scattering cross-section due to the 
distance dependence of plasmon coupling89,101. This effect causes a nearly 2-fold 
increase in the fraction of the VLPs above Var(P) noise threshold as we move from l 
= 1 to 2 or 3. This difference in behavior was also observed in our in-silico results 
simulating one and two spherical SNPs diffusing on a VLP surface as shown in Figure 
3.5. We observed that when the individual SNPs are attached to the VLP surface as 
opposed to the substrate, nearly 50% of them are above the Var(P) noise threshold 
(Figure 3.2a) as opposed to the 29% observed above. Consequently, we concluded 
that in addition to the SNP shape anisotropy, a coupling is occurring between 
individual SNP labels and the underlying dielectric VLPs in the form of an induced 
mirror dipole. To test this in-silico, we simulated the PFTs generated by 1 perfectly 
spherical SNP label moving randomly (for simplicity) on the surface of a VLP in 
parallel with 2 SNP labels moving on a VLP, while the 2 SNPs were never allowed to 
be closer than 10 nm to each other due to repulsive DNA surface layers on both NPs. 
However, among the random diffusions we included particular configurations of the 
SNP labels on the VLP where they can cause the largest polarization anisotropies. 
Those are the SNPs being exactly on the sides of the VLP, where merely a vectorial 
addition would cause the polarization of scattered light along the longitudinal axis, 
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or the 2 SNP labels being in close proximity of each other and allow for strong 
plasmon coupling. The results of these simulations can be seen in Figure 3.5. As 
expected, while the SNP monomer can cause P fluctuations to a significant level, the 
SNP dimer causes a larger fluctuation in P due to not only the addition of a second 
particle and increase in the SNP-dielectric interaction, but also the presence of 
plasmon coupling which strongly enhances the polarization anisotropy. 
 
Figure 3.5  Comparing 1 versus 2 spherical SNP labels in-silico. (a) PFTs of 1-SNP and 2-SNP cases 
obtained through FDTD simulations. While most configurations are randomly-selected, two special 
cases of strong polarization anisotropy for the 2-SNP case are included among the other 
configurations. For the 1-SNP case, as well, the configuration with maximum anisotropy (SNP on one 
side of the VLP) is included, and yielded its largest P value. (b) E-field maps for the two special 
polarization values shown in (a) are included (incident light being polarized along the dimer axis) 
showing an increase in the E-field intensity along the longitudinal axis of the SNP dimer as their 
interparticle separation becomes 10 nm. The Var(P) for 1-SNP trajectory is 0.0086, while it is 0.0634 for 
the 2-SNP case. 
 
A systematic comparison of the Pearson’s correlation coefficient, ρ, between P and 
𝐼𝑡 for nearly 40 monomers and small clusters (Figure 3.2d) confirms that the dimers 
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and trimers show a significantly stronger (p < 0.001) correlation between P and 𝐼𝑡 
than the monomers. The decrease in Var(P) for  l > 3 is related to a decrease in 
polarization anisotropy of the SNP cluster going from dimers and trimers to larger 
clusters. Therefore, we conclude that there are various factors contributing to the P 
fluctuations and Var(P), including SNP shape, metal-dielectric interaction and 
vectorial addition of the scattering along the longitudinal axis of SNP label(s) and 
VLP, in addition to the plasmon coupling between SNP labels. 
3.3 Comparison of gold and silver as NP labels for PFTM 
In the next step, we compared the performance of SNPs used in Figure 3.2 with that 
of GNPs of identical size. GNPs are usually the preferred choice for optical sensing 
applications due to their higher colloidal and chemical stability. To obtain GNP-
labeled VLPs (GNP-VLPs), the GNPs were attached to the membrane using the same 
AnxV-NTV chemistry used for SNPs. Intriguingly, we found that under identical 
experimental conditions only 10% of the GNP-VLPs lie above the Var(P) threshold 
defined by the polystyrene beads (Figure 3.6), which compares to approximately 
70% for the SNPs. The difference between GNPs and SNPs can be attributed to two 
main effects. The polarizability and scattering cross-sections of the GNPs (and their 
clusters) is smaller than that of SNPs (and their clusters) as shown in the Figure 3.3, 
and in addition, the distance dependence of the plasmon coupling has a steeper 
slope for SNPs than for GNPs89. At a given separation, the polarization anisotropy 
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for SNPs is generally higher than that for GNPs and smaller changes in separation 
lead to larger signal fluctuations in the case of SNPs. Our analysis confirms that 
SNPs are better suited for characterizing NP diffusion through PFT analysis. In 
addition, compared to nanorods used in other time-resolved applications129,130, they 
are easier to synthesize and also to be used in optical set-ups due to their visible-
range plasmonic resonances. 
 
Figure 3.6 Silver NPs prove to be better than gold NPs as labels in this application of PFTM. Scatter 
plot of Var(P) as function of trajectory-averaged total intensity, 𝐼?̅?, for GNP- and SNP-labeled VLPs. 
Inset: Fraction of NP-labeled VLPs with Var(P) values that are at least three standard deviations 
higher than the Var(P) of polystyrene NPs with the same intensity. Background: Histogram of Var(P) 
as function of 𝐼?̅? for GNP- and SNP-labeled VLPs. 
 
3.4 The diffusion of NP labels on VLPs is non-Brownian 
We hypothesized that PFTs of SNP-VLPs provide insight into the membrane fluidity 
and its change as function of chol depletion on the single-VLP level. As a first step 
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towards a systematic prediction of the membrane behavior under different lipid 
compositions and temperature conditions, we performed MD simulations for the 
lateral diffusion of PS lipids in a model virus membrane. The latter comprised a 
ternary mixture of the main components of the HIV-1 membrane: 
dipalmitoylphosphatidylcholine (DPPC), chol, and dioleoyl-sn-glysero-3-phospho-
L-serine (DOPS). The DOPS concentration was kept constant at 10 mol%, while the 
DPPC and chol concentrations were systematically varied. The simulations were 
performed at different temperatures in order to find the trend of the membrane 
fluidity change as a function of chol content at different temperatures (Figure 3.7). 
Based on these simulations, MSD for each condition was plotted versus time (Figure 
3.8) and diffusion coefficients were calculated (see Materials and Methods section). 
As shown in the MSD plots, the change of fluidity due to chol content change is 
temperature dependent. While at 25 and 40 ˚C (below the transition temperature of 
42 ˚C for a binary DPPC-chol system134) the increase in the chol content increases 
the fluidity, but at 50 ˚C it decreases the fluidity. We can explain this behavior 
according to the phase diagrams for such lipid mixtures and the coexistence of 
different phases at each particular condition. The pure phases are in sequence of 
decreasing fluidity: 1) liquid-disordered (Ld), which is a uniform fluid; 2) liquid-
ordered (Lo), which forms rafts; and 3) solid-ordered (So), which is a gel phase. 
Assuming that the phase behavior of the ternary DPPC-chol-DOPS system is similar 
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to the DPPC-chol system, which is a justified assumption given our low DOPS 
concentration, we expect a coexistence of the So and Lo phases at 40 ˚C. Since pure 
So exhibits lower diffusion than Lo and increasing chol content favors Lo, the 
membrane fluidity is expected to increase with chol content as the more fluid phase 
becomes more prevalent. At 50 ˚C, and low chol content, the system is in the 
coexistence region of Ld + Lo, and shows a high diffusion constant. Increasing the 
chol content favors again the Lo phase and decreases diffusion because of an 
enrichment of the less diffusive phase. 
 
Figure 3.7 Simulated translational diffusion trajectories of DOPS lipid in bilayers with 2 chol contents 
at 3 different temperatures. Each trajectory shows 250 ns of diffusion. The temperature- and chol-
dependent change in the MSD can be seen in the plotted trajectories. 
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Figure 3.8 Simulated mean squared-displacement (MSD) plots for 10% and 40% chol containing lipid 
bilayers at 3 different temperatures. Diffusion coefficients were calculated based on these plots (see 
Methods). 
 
The simulations (Figures 3.7, 3.8 and 3.9b) reveal that the change in diffusion 
coefficient, D, as a function of chol concentration is temperature dependent. Figure 
3.9b shows D as a function of chol concentration at 40 ˚C and 50 ˚C (based on 
simulated MSD plots shown in Figure 3.8). These temperatures were chosen as they 
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frame the So to Ld transition temperature in the DPPC-chol binary system (no 
DOPS). D increases with increasing chol content at 40 ˚C, but the trend reverses (D 
decreases with increasing chol content) at 50 ˚C. At 25 ˚C, the MDS plots show a 
trend with varying chol content similar to the ones at 40 ˚C, but the absolute values 
are lower. Similar trends in D for different temperatures have been reported before 
with different membrane compositions28. The different temperature dependencies 
in Figure 3.9b can be rationalized by considering the fluidities of the different phases 
in the DPPC-chol binary phase diagram134, as explained above. Our MD simulations 
predict the diffusion coefficient of an individual PS lipid, while in our experimental 
conditions each AnxV protein (the linker between PS and each SNP) binds to several 
PS lipids135. The connection between the behavior of individual lipids and lipid 
clusters is provided by the Saffman-Delbrück model, which predicts that D of the 
lipid cluster shows a rather weak size dependence that scales with ln(1/R) where R 
is the radius of the lipid cluster136. Multivalent attachment of SNPs to the viral 
membrane will, therefore, systematically decrease the numerical value of D for 
SNPs131, but is assumed not to change the phase behavior of the supporting 
membrane. 
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Figure 3.9 Chol content change affects the membrane fluidity and NP labels’ behavior in different 
ways depending on temperature. a, Snapshot of an MD simulation for the diffusion of an individual 
DOPS (orange) lipid in a membrane composed of DOPS (green), DPPC (gray), and chol (red). The 
trajectory of the orange DOPS molecule over a time frame of 250 ns is included in blue. b, Simulated 
diffusion coefficient, D, for DOPS at various chol concentrations and two temperatures (40°C and 
50°C). c,d, Experimental PFTs for individual SNP-VLPs measured before and after chol depletion at 
25˚C and 45 ˚C, respectively. e, PP. aft. as function of Pp. bef  (see text) for individual SNP-VLPs. Inset: 
Correlation coefficients, ρ, for Pp. bef. and PP. aft. calculated for the two temperatures. f, Model to 
account for the differences in correlation between Pp. bef. and PP. aft. at low and high temperature 
(LT or HT). In LT, the system can get frozen in a high energy configuration while in HT, the system 
can localize to the energetically favored config uration. 
As discussed above, the experimentally-recorded PFTs do not support the model of 
a random diffusion within a confinement defined by the VLP. Instead, fluctuations 
of the polarization between distinct P values indicate a hindered diffusion in which 
the NPs commute between different discrete trap sites. In the presence of chol, 
frequent rapid transitions between different configurations are observed at both 25 
˚C and 45 ˚C (two temperatures below and above the phase transition temperature 
of the viral membrane30), as shown with the blue PFTs and their corresponding 
histograms in Figures 3.8c,d. More PFT histograms are shown in Figure 3.10. In order 
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to test if the PFTs that were measured for the VLPs are reproducible in terms of the 
absolute values of P and its Var(P), we measured the PFTs for the same VLPs 3 times 
with 5 minutes delay each time. The histograms of the PFTs obtained for 3 VLPs are 
shown in Figure 3.10a. We can see that the P distribution is reproducible in each 
VLP and that it does not shift significantly. However, when we treated the VLPs with 
5 mM MβCD we generally observed a sharpening in the P distribution as shown in 
supplementary Figures 3.10b,c. Although this sharpening was observed as a general 
effect independent of temperature, the location of the peak P value after chol 
extraction (PP.aft.) was not temperature-independent. At 25 ˚C, PP.aft. can assume any 
value within the envelope of the P distribution before chol extraction, including 
those associated with a low-probability configuration (Figure 3.10b). At 45 ˚C, PP.aft. 
was often identical to the peak polarization value before chol extraction, PP.bef. 
(Figure 3.10c). 
Energetic differences between the geometric configurations (Si) result in different 
occupation probabilities, which are quantifiable through the measured P 
distributions. P values with the highest probability indicate energetically-favored or 
“low energy” configurations while P values with lower probability indicate “high 
energy” configurations. At both 25 ˚ C and 45 ˚ C, extraction of chol with 5 mM MβCD 
reduces the frequency of interconversion between the different NP configurations, 
increasing the contribution from one configuration at the expense of the others. 
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This behavior is illustrated with the orange PFTs recorded after chol extraction and 
their corresponding histograms in Figures 3.9c,d.  
We calculated the Pearson’s correlation coefficient (ρ) between the most probable 
or “peak” polarization before (Pp. bef.) and after (PP. aft.) chol extraction for eight 
individual SNP-VLPs at the two different temperatures (Figure 3.9e). We find a 
strong correlation with ρ = 0.97 at 45˚C, while at 25 ˚ C the correlation is weaker with 
ρ = 0.76. Interestingly, we are experimentally observing that at 45 ˚C chol depletion 
often leads the system to preferentially take the lowest energy configuration 
observed before chol extraction (PP. aft. often gets associated with Pp. bef.), while at 25 
˚C there is a non-negligible probability for the system to get trapped in the high 
energy configuration. Consequently, we propose the following model to account for 
the experimental observations, as demonstrated in Figure 3.9f. For a set of SNP 
configurations, Si, associated with light polarizations Pi, the activation barrier for an 
interconversion between Si’s increases with decreasing membrane fluidity. At HT, 
chol removal increases the membrane fluidity (Figure 3.9b) resulting in sufficiently 
shallow barriers, which allows the system to localize to the energetic minimum, S1. 
But at LT, chol removal decreases the membrane fluidity and increases the energetic 
barriers between the different configurations. In this condition, the system can get 
trapped and “freeze” in a high energy configuration, S2. The stronger correlation 
observed for 45 ˚C experiment in Figure 3.9e is in accordance with our model which 
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mechanistically explains the NP labels’ configurational behavior that causes the 
observed narrowing of the PFTs’ histograms and decrease in their Var(P) as a 
consequence of chol extraction from VLPs’ membranes. Although we are proposing 
our model based on a two-“state” system, the SNP labels can acquire any number of 
preferred configurations (and local P maxima in PFT histograms), as shown in the 
examples of Figures 3.10b,c. 
 
 
 
Figure 3.10 a, Histograms of thee independently measured PFTs  for the same VLP. b, Change of the P 
distribution as a consequence of chol depletion at 25 ˚C. c, Change of the P distribution as a 
consequence of chol depletion at 45 ˚C. 
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3.5 PFTM for tracking the kinetics of chol extraction on a single-virus level 
To corroborate that the Var(P) associated with the confined diffusion of the NP 
labels is a useful measure to detect chol-mediated changes in the membrane fluidity, 
we analyzed P trajectories from 130 individual VLPs before and after chol extraction 
with 5 mM MβCD at 40 ˚C. The resulting Var(P) data are shown in scatter plot and 
histograms in Figure 3.11a, with Var(P)bef and Var(P)aft showing the Var(P) values 
before and after chol extraction, respectively. In this analysis, we used VLPs with 
Var(P) values above 0.005 (a threshold required for a properly high sensitivity of the 
assay) and found that the Var(P) distribution shows a significant (p = 0.01) shift to 
smaller values after chol extraction. 
 
Figure 3.11 Chol extraction kinetics can be tracked in HIV-1 VLPs on a single-virus level. (a) Chol 
extraction from the membrane of HIV-1 VLPs with MβCD at 40 ˚C significantly (p = 0.01) shifts the 
Var(P) distribution as shown in the histograms. Data points below the dashed line are the individual 
VLPs whose Var(P)s have decreased. (b)  Var(P) corresponding to a 50% probability in the cumulative 
distribution, V0.5, as function of time for treatment with 2 mM and 10 mM MβCD. (c) Characteristic 
extraction time, τ, determined for individual VLPs upon chol extraction with 2 mM and 10 mM MβCD 
and their corresponding box plots.  τ is the time until Var(P) has dropped to 1/e of its initial value. * 
indicates a paired Student’s t-test p-value below 0.05. 
To prove what we are observing is the direct effect of chol content change, similar 
measurements were performed on two liposome samples (unilamelar liposomes 
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~120 nm in diameter) with 10 and 40 mol% chol concentrations, and cumulative 
probabilities of Var(P) were plotted for them, in parallel with a Laurdan GP 
measurement137 on the same samples (Figure 3.12). We prepared liposomes with 
known chol contents (10 and 40 mol% similar to the expected values for HIV-1 VLPs 
before and after chol extraction) and, similar to the PS labeling on VLPs, we attached 
SNP labels on them to measure their PFTs at 40 ˚C near the physiological 
temperature. The measurement was done on nearly 150 liposomes in each condition 
and their PFTs were obtained so that we can plot the Var(P) cumulative probabilities 
for the individual populations. Similar as in the case of chol extraction in VLPs 
(Figure 3.11a), we observe a shift to smaller values for Var(P) as a result of chol 
content decrease in the liposomes (Figure 3.12a). As a validation of our MD 
simulations and the experimental observations on the VLPs and liposomes, we 
measured the difference in the fluidities of the same liposome samples through a 
standard Laurdan generalized polarization measurement (Figure 3.12b). To that end, 
liposomes were generated containing a small fraction of Laurdan fluorescence probe 
(see Materials and Methods section). The Laurdan measurements validated the 
presence of a systematic difference in the fluidities of the two liposomes with 10 and 
40 mol% chol, with the 10% chol sample showing a significantly higher fluidity at 
high temperatures such as 50 ˚C consistent with our MD simulations and PFT 
changes as shown in Fig. 3.9. At 40 ˚C (or lower temperatures), our MD simulations 
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predict a lower fluidity for the low chol content sample and we have been able to 
record that through PFTM as shown in the Figure 3.12a. Both of these measurements 
verified a systematic difference in the observed responses (Var(P) and GP) as a result 
of the difference in chol contents. The observed decrease in Var(P) of VLPs and the 
narrowing of the distribution did not occur in the negative control in which the 
sample was treated with pure buffer or 0 mM MβCD (Figure 3.13).  
 
Figure 3.12 a, Cumulative probability plots of Var(P) obtained from the PFTs of two populations of 
nearly 150 liposomes (each) containing 10 and 40 mol% chol at 40 ˚C. Error bars show the standard 
deviation of the mean. b, Laurdan GP fluorescence measurements for the same liposomes.  
 
Figure 3.13 Negative control for chol depletion (SNP-VLP sample flushed with pure buffer). There is a 
non-significant change in the Var(P) histogram after flushing the VLPs with pure buffer rather than 
MβCD. 
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In the next step, we recorded the PFTs of a population (5 x ~50) of SNP-VLPs at six 
consecutive time points (0, 0.5, 1, 2, 5 and 10 min) after incubating them with two 
different concentrations of MβCD (2 mM and 10 mM) at 40 ˚C and quantified their 
Var(P). Cumulative Var(P) distributions for the VLP population show a continuous 
shift to smaller values with increasing incubation time (Figure 3.13). This trend is 
illustrated in Figure 3.10b by a plot of 𝑉0.5, which is the Var(P) value corresponding 
to a 50% probability in the cumulative distribution, as function of time. The plots 
show a continuous decrease that is well described by a fit of the form: 
𝑉0.5(𝑡) = 𝑉0.5
0 + (𝑉0.5
𝑚𝑖𝑛 − 𝑉0.5
0 ) ∗ (1 − 𝑒−𝜏𝑡),   3.2 
where 𝑉0.5
0  is the initial value of 𝑉0.5 (at time 0 min), 𝑉0.5
𝑚𝑖𝑛 is the minimum value that 
𝑉0.5 acquires, τ is the characteristic extraction time, and t is the time of chol 
depletion. Based on this model, the characteristic time of chol depletion with 2 mM 
MβCD, τ2mM, was found to be 1.0 min, while with 10 mM MβCD we obtain τ10mM= 0.5 
min. These values indicate the ensemble behavior of the VLP populations under the 
two different treatments.  
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Figure 3.14 Cumulative probability plots derived from the histograms of Var(P) for various time 
points during the depletion of chol with 2 and 10 mM MβCD. 
  
Since the PFT approach provides P information of individual VLPs, we can 
determine τ values for individual VLPs also by fitting the change in Var(P) of each 
VLP at different time points (0, 0.5, 1, 2, 5 and 10 min) with the above model, and 
calculating the characteristic time of chol depletion. This alternative approach offers 
a unique insight into the heterogeneity of the chol extraction among the individual 
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VLPs. Figure 3.11 c compares the single-VLP τ values for the two investigated 
conditions (we have included only the cases with a goodness of fit above 0.9). The 
distribution of chol depletion times is broader for 2 mM MβCD, indicating a more 
heterogeneous extraction behavior in this case. We attribute the higher 
heterogeneity to the fact that in the case of a lower MβCD concentration, 
characteristic parameters of the individual VLPs, such as size, curvature, membrane 
composition, density, and nature of surface proteins have more leeway in perturbing 
the chol depletion. In general, the heterogeneity observed in chol extraction kinetics 
indicates a variability in the VLP membrane that could lead to different efficacies in 
early steps of virus infection that include host cell binding and infection. 
3.6 Conclusions 
We have demonstrated that the polarization fluctuations of SNPs labeled to 
individual VLPs depend on the fluidity of the membrane, which we utilized for 
monitoring chol extraction on the single VLP level. Due to the small size of virus 
particles, co-confinement of multiple NPs on the virus surface results in enhanced 
polarization fluctuations due to distance dependent plasmon coupling. We detected 
systematic changes in the polarization fluctuations as response to chol extraction 
through MβCD at temperatures below and above the phase transition temperature. 
At both temperatures the PFTs were indicative of confined, non-Brownian diffusion 
in which the NPs switched between different geometric configurations. Whereas 
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chol extraction at low temperatures “froze” the NPs in the configuration that they 
were presently occupying, at high temperatures the NPs relaxed preferentially into 
the low energy configuration. A characterization of the impact of chol extraction on 
Var(P) for the VLP ensemble at 37°C revealed a loss of lateral mobility of the NPs 
and a sharpening of the var(P) distribution. The sharpening of the distribution, 
together with a broad spread of extraction rates for individual VLPs, in particular, 
at low MβCD concentrations, indicates some heterogeneity in the membrane chol 
content between individual VLPs. Given the relevance of chol for viral 
function7,66,67,138,139, virion-to-virion differences in chol content is expected to create 
variability in the infectivity. PFTM provides now an optical tool to quantify this 
heterogeneity and, thus, paves the path to future studies in which the impact of 
membrane heterogeneity on specific biologically relevant outcomes, such as host 
cell binding affinity, fusion with the host cell plasma membrane, Env protein 
maturation, and others can be established. These studies will help to elucidate the 
role that the host-derived membrane plays in shaping HIV-host cell interactions. 
3.7 Materials and Methods 
FDTD simulations and PFT generation: FDTD simulations were performed with the 
Lumerical Solutions 8.17.1 software package, as described previously103. The mesh 
size of these simulations was always 5 nm, except for the 10 nm separation and near-
field maps where we had 2 nm mesh size and a secondary 0.5 nm gap mesh size. The 
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substrate was chosen as glass with a refractive index of 1.517. Virus-like particles 
(VLPs) and liposome were emulated as dielectric beads with a diameter of 150 nm 
and a refractive index of 1.500. The refractive index of the medium was set to 1.335. 
Silver nanoparticles (NPs) were assumed to be 40 nm in diameter and we used the 
silver dielectric function given by Johnson and Christy126. The light source was 
always a planar wave with its propagation direction normal to the substrate and 
wavelengths scanning 300 to 800 nm with two perpendicular polarizations 
calculated separately. The detectors in this simulation were 6 planar far-field 
detector placed normal to X, Y and Z axes. The integrated area under each spectrum 
was calculated as the intensity in that particular polarizations (𝐼∥ and 𝐼⊥). Two SNPs 
were moved on the surface of the VLP randomly using a random spherical 
coordinate generator in Matlab while we always assumed a minimum spacing of 10 
nm between the NPs. These random coordinates simulate a Brownian diffusion by 
the SNPs on the surface of the VLP. The NPs were placed 5 nm away from the VLP 
surface, assuming a 5 nm thickness for the ssDNA shell on the NPs under 
experimental conditions. 
VLP generation: HIV-1 VLPs were synthesized as described before103. Briefly, the 
expression plasmid, HIV-1 Gag-eGFP was provided by NIAID AIDS Reference and 
Reagent Program (ARRRP; contributed by Drs. Marilyn D. Resh and George 
Pavlakis). VLPs were synthesized by transfecting HEK 293T cells with a Gag-eGFP 
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expression vector. VLPs were purified and concentrated from culture supernatant 
through filtration and ultracentrifugation (24,000 rpm at 4˚C for 2 hr with a SW32Ti 
rotor, Beckman) on 20% sucrose cushion. The size and concentration of different 
stocks of VLPs were measured by Malvern ZetaSizer (Nano ZS90) and iZon’s qNano 
particle counter or p24gag ELISA assay.  
Liposome synthesis: In the first step, lipids in a defined ratio were dissolved in 
chloroform. The lipid mix consisted of 1,2-dipalmitoleoyl-sn-glycero-3-
phosphocholine (DPPC), Cholesterol and 1,2-dioleoyl-sn-glycero-3-phospho-L-
serine (DOPS), all purchased from Avanti Polar Lipids, Inc. The cholesterol 
concentration was adjusted on 10 and 40 mol%, 0.1% of which was fluorescently 
labeled with TopFluor. In addition, 0.1% Laurdan fluorescence probe was added to 
all the mixtures for GP measurements. The DOPS concentration was kept constant 
at 10% and the DPPC concentration was accordingly adjusted to be 80 or 50 mol%. 
The total concentration of lipids in 150 µl of chloroform was 7 mM.  
The chloroform in the lipid solution was removed with a rotary evaporator 
connected to vacuum at room temperature. The flasks containing the lipids were 
left in vacuum overnight. Then, 1 mL of 20 mM HEPES buffer (pH=7) was added to 
each flask and it was sonicated in a bath sonicator for 60 min at room temperature. 
This colloid of synthesized liposomes was extruded through a 100 nm polycarbonate 
membrane 9 times while maintaining a temperature of 40˚C on a hot plate. The 
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liposomes were subsequently stored at 4˚C. Average size and concentration of the 
liposomes were measured through dynamic light scattering (DLS) with a Malvern 
ZetaSizer. Concentration was measured based on the count rates in dynamic light 
scattering tests on serial dilutions of the sample and using Concentration Utilities 
of ZetaSizer software. 
DOPS labeling on VLPs and liposomes with SNPs and GNPs: 40 nm silver and gold 
NPs (from TedPella Inc.) were functionalized with single stranded DNA 
oligonucleotides using the method by Liu et al127. The oligonucleotides HS-
AAAAAAAAAACTCACGCTAC-GACTGACACC and HS-
AAAAAAAAAAGACCTACTAAGACTACTACACAACCAGAGA-Biotin 
oligonucleotide were mixed in a 4:1 ratio. This mix was added to nanoparticle colloid 
in DDI water to yield a final concentration of 25 µM DNA and 1.5 nM nanoparticles 
in a total volume of 10 µl and incubated for 30 min at room temperature. The pH 
was then lowered to pH = 3 by adding 10 mM sodium citrate buffer in a negligible 
volume. The mix was incubated for another 30 min. After that, the nanoparticles 
were washed by repeated centrifugation (2,400 ×g for gold and 5,000 xg for silver 
NPs, 10 min) and resuspension in 1.5 mL in DDI water. After the third washing step, 
the NPs were passed through a 0.22 µm syringe filter to remove any agglomerates or 
impurities. The particles were then collected by a final round of centrifugation. The 
resulting DNA-conjugated NP pellet was diluted with DDI water before 10x PBS was 
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added to reach a final concentration of 0.15 nM NPs in 1x PBS. The volume of added 
PBS was adjusted in experiments that required higher/lower concentrations. The 
concentration, size and zeta potential of the NPs were measured in 1x PBS buffer by 
UV-Vis spectrometer and Malvern ZetaSizer right before use.   
PS in the VLP/Liposome membrane was functionalized with biotinylated Annexin 
V (Abcam), using a 10000:1 ligand:VLP ratio. For this purpose, 107 VLPs/liposomes 
in 0.5-2 µL of stock were added to 10 µL of 1x Annexin Binding Buffer (ABB: 10 mM 
HEPES pH = 7.4, 137 mM NaCl, 2.5 mM CaCl2) and 0.5 µg of AnxV was added and 
incubated for 30 min at room temperature. Then, an 8-fold excess of neutravidin 
(NTV, Thermoscientific Inc.) in PBS and 1% Bovine Serum Albumin (BSA) were 
added and incubated for 30 min at room temperature. Subsequently, the 
functionalized VLPs were purified from excess proteins in solution through 
ultracentrifugation (Beckman-Coulter Optima TLX) on 60% sucrose cushion (100k 
×g, 30 min, 4˚C). Liposomes were purified by 24-48 h of dialysis against 1x ABB using 
a 100 nm pore size polycarbonate (PC) membrane in a micro-dialyzer (Harvard 
Apparatus Inc.) in an ice bath. The functionalized VLPs/liposomes were diluted to 
150 µL in ABB, and stored at 4˚C for experiments during the following week. This 
amount of functionalized VLPs/liposomes was enough for at least 3 optical 
measurements or 5-10 electron microscopy samples.  
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Sample Preparation for Optical Measurements: The functionalized VLPs, in 50 µL 
ABB, were flushed into rectangular borosilicate capillaries (100 × 2 × 0.1 mm3, from 
Vitrocom), where they stuck non-specifically to the fused silica surface. Under 
typical experimental conditions, the VLPs were incubated until approx. 50 VLPs 
were bound in the field of view to avoid interference between the individual VLPs 
(this step took normally around 30 min at 4˚C). We used VLP samples with a 
concentration of 6x104 VLPs/μL and consumed a total of ~3x106 VLPs per 
experiment. After that, excess VLPs were removed by flushing the chamber with 1x 
ABB. The surface was then blocked by 10% BSA in 1x ABB for 2 hr at 4˚C. After 
washing the samples with 1%BSA in 1xPBS, the samples were incubated with 0.1 
mg/mL polyinosinic acid (PI) in 1%BSA/1xPBS for 30 min at room temperature. PI 
was subsequently removed by flushing the flow chamber with 1%BSA in 1xPBS. In 
the next step, the immobilized VLPs were incubated with a 1.5 nM solution of biotin-
functionalized silver or gold nanoparticle labels in 1x PBS for 15 min at room 
temperature. Unbound nanoparticles were flushed out with 1x PBS containing only 
20 mM NaCl.  
EM Sample Preparation: Electron Microscopy samples were prepared similar to 
optical measurement samples, except the substrate was a 5 mm × 5 mm silicon chip 
for SEM samples and a 9-window SiN grid for TEM samples (from Ted Pella Inc.). 
Also, the EM samples went through fixation or negative staining or both after silver 
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or gold NP label binding. For TEM samples, 5 µl of the functionalized VLP stock was 
initially incubated on an SiN grid for 1 hr at 4˚C. Then, the surface of the chip was 
flushed by pipetting 50 µL of ABB on the chip 3 times. Then, 10%BSA in ABB was 
incubated on the chip for 2 hr at 4˚C. The chip was subsequently washed with PBS 
3 times before 0.1 mg/mL PI in PBS was incubated on the sample for 30 min at room 
temperature. Then, the sample was washed with 1%BSA in 1x PBS and conjugated 
gold NPs in PBS were incubated on the substrate for 15 min at room temperature. 
Then the sample was washed again with PBS. NP-labeled VLP samples were 
incubated with 2.5% glutaraldehyde (Sigma-Aldrich) in 1x PBS for 30 min and 
subsequently with 1% OsO4 in PBS (50 mM salt) for 30 min at room temperature. 
The TEM samples were then washed with water and air dried. The samples were 
stained with 1% sodium phosphotungstate in water (pH=7.4) for 30 seconds, blotted 
and then dried. SEM samples of the silver NPs were prepared by incubating the 
colloid of the NPs on silicon chips and letting it dry at room temperature. 
SEM and TEM Characterization: SEM samples were coated by a thin layer of Au/Pd 
using a sputter coater to provide conductivity. SEM imaging was performed on a 
Zeiss Supra 55 VP scanning electron microscope with 10 kV EHT. TEM imaging was 
performed by a JEOL JEM 2010 scope with 200 kV acceleration voltage. 
Dark-field microscopy: All imaging experiments were performed with an inverted 
microscope (Olympus IX71) equipped with an oil immersion dark-field condenser 
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and 60x objective. The sample was illuminated with a 100 W Tungsten lamp through 
a high numerical aperture (NA = 1.20) dark-field condenser. The scattered light was 
split according to polarization using a polarizing beam splitter and two images of 
the entire field of view (128 x 128 pixels = 62 x 62 μm2) with orthogonal polarizations 
were recorded on two separate electron multiplying charged coupled device 
(EMCCD) cameras with a frame rate of 500 fps. Each field of view contained 
approximately 50 individual VLPs under typical experimental conditions. The 
experimental  𝐼∥ and 𝐼⊥ values were determined by fitting the point-spread-functions 
of the labeled VLPs to 3D-Gaussians and integrating the volumes under the surfaces. 
In addition to the scattering channel, the microscope was equipped with an epi-
fluorescence channel to record a fluorescence image (400/530 nm 
excitation/emission filters and a 470 nm dichroic) of the same field of view. Images 
were all recorded with Andor iXon EMCCD cameras. To obtain scattering movies, 
we recorded 2000 frames each with 2 ms exposure time (500 fps) per experiment 
with an electron multiplier gain of 50. For fluorescence measurements, we used an 
exposure time of 1 sec and an electron multiplier gain of 100. The 60x objective had 
a variable numerical aperture (NA), so the scattering images were recorded with NA 
= 0.65 and the fluorescence images were recorded with NA = 1.25. To account for the 
spectral profile of the Tungsten lamp used as excitation source the intensities were 
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corrected by dividing through the corresponding average scattering data obtained 
from 200 nm polystyrene nanoparticles.  
Movie data processing and obtaining PFTs and Var(P): All image processing and data 
analysis was performed using a home-written Matlab code. The point-spread-
function (PSF) of every VLP in each frame of the movie in both orthogonal 
polarization CCD images were fitted with Gaussian functions of the form: 
𝐺(𝑥, 𝑦) = 𝐴𝑒
−[
(𝑥−𝑥𝑜)
2
2𝜎𝑥
2 +
(𝑦−𝑦𝑜)
2
2𝜎𝑦
2 ]
+ 𝐵𝐺 , 3.3 
where xo and yo are the Gaussian peak position, σx and σy are the full width at half 
maximum of the Gaussian along x and y directions, A is the Gaussian amplitude, and 
BG is the background. After subtracting the background (BG), the integrated 
intensity of the PSF was taken as the scattering intensity of the VLP/liposome at that 
specific 2 ms frame. Performing this Gaussian fitting on tens of particles in each field 
of view for 2000 frames per experiment takes a very long CPU time and many CPUs 
to be time-efficient. Therefore, we implemented the Matlab code in the Boston 
University shared computing cluster (SCC) system to have unlimited access to many 
CPUs at the same time. This enabled us to process a relatively large amount of data 
in a short time. After calculating the scattering intensities in orthogonal 
polarizations, 𝐼∥ and 𝐼⊥, we calculated P for each frame to obtain the polarization 
fluctuation trajectory (PFT), its variance over the 2000 frames, Var(P), the total 
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intensity per each frame, 𝐼𝑡 = 𝐼∥ + 𝐼⊥, and the average total intensity over the full 
trajectory, 𝐼𝑡 =  
∑ (𝐼∥+𝐼⊥)
2000
1
2000
. 
Noise threshold determination based on the PFTs of immobilized polystyrene NPs: 
Carboxyl-terminated Polystyrene NPs 200 nm in diameter were dispersed in PBS 
buffer similar to that used for VLPs and then flushed in the capillary tubes while 
being monitored in the dark-field microscope. As soon as nearly 100 of the NPs were 
observed to be electrostatically attached to the quartz substrate, the remaining free 
particles were washed out by PBS. Movies of these immobilized NPs at the two 
orthogonal polarization channels were recorded at different intensities of the 
incident light by starting from the highest intensity of the tungsten lamp and 
repeating the measurement after serially turning down the intensity manually. The 
PFT of each NP was calculated as described above at the different recoded intensities 
down to the lowest intensity with which still a reasonable goodness of fit could be 
achieved in the Gaussian fitting (r2 above 0.7). Based on these data, the scatter plot 
of Var(P) vs. 𝐼𝑡 for each NP at each intensity was plotted (Figure 3.2a) in order to 
find the noise threshold in different intensity intervals. In this plot, for each 0.2 
interval on the intensity axis, the 3rd standard deviation from the mean of the 
population in that interval was calculated as the threshold below which the noise in 
the PFT signal becomes dominant over the actual polarization fluctuations. 
Therefore, if the Var(P) for a particle with a particular total scattering intensity, 𝐼𝑡, 
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is above this calculated noise threshold, its PFT was regarded as dominated by the 
actual polarization fluctuations coming from changes in the particle or labels’ spatial 
configuration and used for further analyses. 
Molecular Dynamics (MD) simulations: Computational bilayers were prepared with 
CHARMM-GUI140–142 using the CHARMM36 force field143. Fully hydrated bilayers, 50 
waters per lipid, with 100 lipids per leaflet with varied cholesterol composition (10%, 
20%, 40% cholesterol) were generated in 20mM NaCl/TIP3P water box. All 
simulations were preformed with GROMACS v5.0.2144–150 with a time step of 2.0 fs 
using a semi-isotropic barostat with target pressure of 1 atm and Nose-Hoover 
thermostat set at either 298 K, 313 K, or 323 K. Systems were equilibrated for 250 ns 
and production data was recorded for an additional 250 ns. Mean-square 
displacements (MSD) were calculated using GROMACS with coordinates that were 
saved every 5000 steps from the production run. Final diffusion constants, obtained 
from the slope of the MSD, were averaged in 5 ns increments of at least 20 ns of data 
starting at 15ns and ending at 60ns to obtain error bars.  
Histograms and cumulative probability of Var(P), calculation and plotting: In the 
cases of studying large populations of SNP-labeled VLPs, Var(P) was calculated for 
each individual VLP as described above and then histograms of the Var(P) values 
were plotted. These histograms were then used to plot the cumulative probability 
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of Var(P) for each population at each condition. The Var(P) of the VLP population 
at which the cumulative probability equals 0.5 was calculated as V0.5. 
chol depletion tracking: chol depletion experiments were performed with three 
concentrations of MβCD, 2, 5 and 10 mM in PBS with 20 mM NaCl, at different 
temperatures depending on the experiment. Movies with 500 fps were recorded 
once before MβCD incubation and then after 0.5, 1, 2, 5, 10 and 20 min after the 
incubation started in order to track the chol extraction. Movies were always 
recorded in triplicates to have the measurement error. In order to study the 
extraction kinetics on an ensemble level, the cumulative probability plots and their 
corresponding V0.5 for all the time points were calculated and used as a quantity that 
its shift to smaller values indicates the reduction of the chol in the VLP membrane. 
However, in case of tracking the chol extraction from single VLPs, the Var(P) itself 
was used as the quantity that its reduction is the indicative of the change in chol 
content in the viral membrane. So, V0.5 for an ensemble of the VLPs was taken as the 
analogue of the Var(P) for an individual VLP.  
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Chapter 4 FUTURE DIRECTIONS 
The techniques that we have developed, as described in chapters 2 and 3, and the 
results that we have obtained through our measurements on VLPs using these 
techniques have created new opportunities for biological studies and nanoscience 
research. In general, the introduced experimental strategies take advantage of the 
plasmon coupling based small-sample lipid quantification strategy and the 
polarization fluctuation-based single-virus membrane fluidity technique to  obtain 
information about the behavior of viral surface lipids and proteins. In addition, as 
shown in section 3.4, we have observed new interesting dynamic nanoscale 
phenomena (NP labels non-Brownian diffusion on the VLP surface) that motivate 
additional studies.. In this chapter, the new research directions that our techniques 
and finding have created will be introduced and a general outline of these future 
research possibilities will be presented.  
4.1 Utilizing the Lipid-Quantification Technique for Novel Virological 
Studies 
As described in chapter 2, section 2.10, immediately after the development of our 
plasmon-coupling based viral lipid quantification technique, as expected, we 
received a significant amount of interest in the application of this technique to in-
depth virological studies. These resulted in our collaboration with virologists from 
Boston Medical Center and the National Cancer Institute, and parts of our findings 
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have been already published by Kijewski et. al.109 and Ahi et. al.110 This was due to 
the need of virologists for novel techniques of lipid quantification on viruses 
through simple and fast procedures, which we had predicted and aimed to satisfy 
with our method. The interest in this technique also emerged from its fundamental 
simplicity enabling the lipid quantification on intact virus particles in their natural 
environment (saline buffer) without a need for sample preparation steps such as 
lipid extraction and/or dehydration. In addition to the fact that our method requires 
very small sample amounts for lipidome analysis. These showed the applicability of 
this technique to deep virological studies including HIV, MLV and Ebolavirus. 
Therefore, we think that this trend can continue with similar virus studies aimed at 
elucidating of how lipidomics impacts viral functions. Moreover, these studies will 
benefit from the simplicity and low sample requirements of the developed 
techniques. 
In addition to their applicability to normal virological studies, our techniques are 
optimized for small sample amounts or low-concentration samples such as patient-
derived samples. Therefore, as long as clinical-relevance of a research is concerned 
these techniques can be helpful. Particularly, considering the lipid abnormalities 
observed in virus-infected patients75, the ability to perform studies on patient-
derived virus samples seems necessary in order to devise personalized medicine. In 
addition, the capability of the technique for looking into sample heterogeneities due 
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to the fact that it is microscopy-based can be advantageous for in-depth analysis of 
patient samples.  
4.2 Molecular Dynamics of Viral Surface Glycoproteins  
In chapter 3, we demonstrated the feasibility of tracking the dynamics of viral 
membrane lipids using plasmonic NP labels. This became possible by binding the 
NPs to the PS lipid through its specific ligand AnxV, as described in section 2.3. This 
strategy can be simply used in the case of viral surface glycoproteins as well. 
Antibodies with very high binding constants for these glycoproteins are available 
and can be used as linkers to bind the NP labels. As shown in our preliminary results 
in the Figure 4.1a, this binding worked very efficiently in the case of targeting gp120 
on the surface of HIV-1 VLPs using its specific antibody and ssDNA-biotin coated 
GNPs. Once we have successfully attached NP labels to the target on the virus 
particle surface, we have the ability to perform several types of measurements for 
characterizing the viral membrane properties. 
Figure 4.1b shows the results of multispectral imaging, as introduced and explained 
throughout chapter 2, of more than 200 individual gp120-labeled HIV-1 VLPs. We 
observed different scattering intensities and resonance wavelengths for individual 
VLPs, indicating different GNP label densities on the surface of VLPs. This can be 
due to heterogeneity in VLP size, gp-120 density per VLP and antibody/GNP labeling 
efficiency. Nevertheless, this observation indicates that we are provided with a wide 
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dynamic range of adjusting NP label density for different applications. If we need to 
use this technique for quantification of gp-120 whose density on virion surface seems 
to play a role in its infectivity71, we need to use higher labeling densities, while in the 
case of researching the dynamics of the glycoprotein we would need a lower density 
of SNP labels on the VLP surface in order to allow free motions of the NP labels. 
 
Figure 4.1 gp-120 labeling on HIV-1 VLPs using GNPs. (a) SEM images showing the binding of multiple 
40 nm GNP labels to gp-120s on the VLPs. (b) Scatter plot of peak intensities and wavelengths of the 
scattering spectra of individual gp-120 labeled VLPs and two exemplary full spectra derived based on 
the intensity data points obtained through multispectral imaging. 
 
 
The spatio-temporal tracking of glycoproteins on the surface of enveloped viruses 
has been a focus of different studies as the spatial distribution of these glycoproteins, 
in addition to their lateral diffusions, seem to play important roles in the virus life 
cycle.69,70,72 The techniques developed and validated in this work, as shown 
throughout chapter 2 and 3, are also suited to study the density and spatio-temporal 
distribution of surface glycoproteins. The advantages that our techniques, in 
contrast with conventional methods such fluorescence-based ones, would provide 
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include higher photostability and the ability for long-term continuous tracking of 
the lateral diffusions of these proteins. 
4.3 Membrane fluidity of different virus mutants 
As shown in section 2.6, different HIV-1 VLP mutants had different lipid 
compositions. This was attributed to different host-cell budding sites. Different cell 
membranes, such as plasma membrane or late endosomal membrane, have different 
lipid compositions114,116. We observed some of these differences in the case of PS and 
GM1 lipids in chapter 2. However, these changes can also influence the chol content 
and fluidity of the membranes and affect the viral infectivity. Therefore, the PFTM 
technique can be utilized to measure the relative differences in the membrane 
fluidities as a consequence of different mutations in the virions, whether it is a 
natural mutation observed in in-vitro or patient-derived samples or it is an 
artificially-induced mutation for research purposes.  
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